Propanc Biopharma (PPCB) S-1 25 Mar 16 IPO registration Financial data

Document And Entity Information

Document And Entity Information	6 Months Ended
	Dec. 31, 2015
Document Information [Line Items]
Entity Registrant Name	Propanc Health Group Corp
Entity Central Index Key	1,517,681
Entity Filer Category	Smaller Reporting Company
Document Type	S1
Amendment Flag	false
Document Period End Date	Dec. 31, 2015

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014
CURRENT ASSETS:
Cash	$ 1,168,118	$ 107,627	$ 87,799
GST tax receivable	6,808	11,647	946
Prepaid expenses and other current assets	327,785	502,616	25,000
TOTAL CURRENT ASSETS	1,502,711	621,890	113,745
Security deposit	1,606	1,684	0
Property and equipment, net	3,671	3,494	0
TOTAL ASSETS	1,507,988	627,068	113,745
CURRENT LIABILITIES:
Accounts payable	107,134	236,466	350,004
Accrued expenses and other payables	43,505	386,311	422,326
Convertible notes and related accrued interest, net	1,949,519	1,794,375	272,424
Loans payable	2,189	27,558	33,909
Embedded conversion option liabilities	2,511,405	780,281	0
Warrant derivative liability	82,086	269,648	158,244
Due to directors - related parties	33,471	35,108	60,350
Loans from directors and officer - related parties	54,005	79,416	161,975
Employee benefit liability	80,538	71,421	62,827
TOTAL CURRENT LIABILITIES	4,863,852	$ 3,680,584	1,522,059
Commitments and Contingencies (See Note 7)
STOCKHOLDERS' DEFICIT:
Common stock, $0.001 par value; 2,000,000,000 shares authorized; 432,719,886 and 347,442,013 shares issued and outstanding as of December 31, 2015 and June 30, 2015, respectively	432,720	$ 347,442	72,685
Additional paid-in capital	21,360,201	17,458,745	16,374,781
Accumulated other comprehensive income (loss)	212,847	100,968	(302,863)
Accumulated deficit	(25,366,632)	(20,965,671)	(17,552,917)
TOTAL STOCKHOLDERS' DEFICIT	(3,355,864)	(3,053,516)	(1,408,314)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	1,507,988	627,068	113,745
Series A Preferred Stock [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock value	5,000	5,000	0
TOTAL STOCKHOLDERS' DEFICIT		5,000	0
Series B Preferred Stock [Member]
STOCKHOLDERS' DEFICIT:
Preferred stock value	$ 0	0	0
TOTAL STOCKHOLDERS' DEFICIT		$ 0	$ 0

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001	$ 0.001
Common stock, authorized shares	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, issued shares	432,719,886	347,442,013	72,684,767
Common stock, outstanding shares	432,719,886	347,442,013	72,684,767
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000	10,000,000
Preferred stock, issued shares	500,000	500,000	0
Preferred stock, outstanding shares	500,000	500,000	0
Series B Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01	$ 0.01
Preferred stock, authorized shares	5	5	5
Preferred stock, issued shares	1	1	0
Preferred stock, outstanding shares	1	1	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
REVENUE
Revenue	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
Administration expenses	996,129	244,431	1,845,108	475,913	1,567,549	742,037
Occupancy expenses	4,889	2,567	9,827	5,344	3,719	11,016
Research and development	142,803	2,443	296,277	6,322	134,319	8,168
TOTAL OPERATING EXPENSES	1,143,821	249,441	2,151,212	487,579	1,705,587	761,221
LOSS FROM OPERATIONS	(1,143,821)	(249,441)	(2,151,212)	(487,579)	(1,705,587)	(761,221)
OTHER INCOME (EXPENSE)
Interest expense	(1,155,645)	(100,176)	(1,574,289)	(648,655)	(1,323,902)	(93,147)
Interest income	0	0	2,027	3	33	18
Other expense	0	0	0	(50,002)	(50,002)	0
Change in fair value of derivative liabilities	(1,347,743)	8,206	(551,890)	122,742	(541,981)	(16,522)
Gain (loss) on debt settlements, net	(58,893)	71,147	(58,893)	34,884	375,547	0
Foreign currency transaction gain (loss)	72,035	(157,655)	(138,704)	(182,612)	(244,332)	(6,959)
TOTAL OTHER INCOME (EXPENSE)	(2,490,246)	(178,478)	(2,321,749)	(723,640)	(1,784,637)	(116,610)
LOSS BEFORE INCOME TAXES	(3,634,067)	(427,919)	(4,472,961)	(1,211,219)	(3,490,224)	(877,831)
INCOME TAX BENEFIT	72,000	82,440	72,000	82,440	77,470	48,267
NET INCOME (LOSS)	(3,562,067)	(345,479)	(4,400,961)	(1,128,779)	(3,412,754)	(829,564)
OTHER COMPREHENSIVE INCOME (LOSS)
Foreign currency translation gain (loss)	(146,551)	103,320	111,879	218,137	403,831	(58,274)
TOTAL OTHER COMPREHENSIVE INCOME (LOSS)	$ (3,708,618)	$ (242,159)	$ (4,289,082)	$ (910,642)	$ (3,008,923)	$ (887,838)
BASIC AND DILUTED NET LOSS PER SHARE (in dollars per share)	$ (0.01)	$ 0	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.01)
BASIC AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING (in shares)	399,822,354	95,007,061	375,025,485	85,827,403	177,633,496	72,350,555

CONSOLIDATED STATEMENT OF CHANG

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Common stock issuable [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Series A Preferred Stock [Member]	Series B Preferred Stock [Member]
Balance at Jun. 30, 2013	$ (792,476)	$ 25	$ 70,632	$ 16,104,809	$ (16,723,353)	$ (244,589)	$ 0	$ 0
Balance (in shares) at Jun. 30, 2013		25,000	70,632,267				0	0
Issuance of stock for services	244,500	$ (25)	$ 1,915	242,610	0	0	$ 0	$ 0
Issuance of stock for services (in shares)		(25,000)	1,915,000				0	0
Issuance of common stock for conversion of accrued expenses	27,500	$ 0	$ 138	27,362	0	0	$ 0	$ 0
Issuance of common stock for conversion of accrued expenses (in shares)		0	137,500				0	0
Foreign currency translation gain/loss	(58,274)	$ 0	$ 0	0	0	(58,274)	$ 0	$ 0
Net loss	(829,564)	0	0	0	(829,564)	0	0	0
Balance at Jun. 30, 2014	(1,408,314)	$ 0	$ 72,685	16,374,781	(17,552,917)	(302,863)	$ 0	$ 0
Balance (in shares) at Jun. 30, 2014		0	72,684,767				0	0
Issuance of common stock for cash	29,000	$ 0	$ 13,400	15,600	0	0	$ 0	$ 0
Issuance of common stock for cash (in shares)		0	13,400,000				0	0
Issuance of common stock for conversion of convertible debt	441,160	$ 0	$ 181,185	259,975	0	0	$ 0	$ 0
Issuance of common stock for conversion of convertible debt (in shares)		0	181,185,110				0	0
Issuance of stock for services	741,276	$ 0	$ 19,258	717,018	0	0	$ 5,000	$ 0
Issuance of stock for services (in shares)		0	19,258,316				500,000	1
Issuance of common stock as part of settlement agreement	152,285	$ 0	$ 60,914	91,371	0	0	$ 0	$ 0
Issuance of common stock as part of settlement agreement (in shares)		0	60,913,820				0	0
Foreign currency translation gain/loss	403,831	$ 0	$ 0	0	0	403,831	$ 0	$ 0
Net loss	(3,412,754)	0	0	0	(3,412,754)	0	0	0
Balance at Jun. 30, 2015	(3,053,516)	$ 0	$ 347,442	$ 17,458,745	$ (20,965,671)	$ 100,968	$ 5,000	$ 0
Balance (in shares) at Jun. 30, 2015		0	347,442,013				500,000	1
Net loss	(4,400,961)
Balance at Dec. 31, 2015	$ (3,355,864)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS	6 Months Ended		12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2014USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,400,961)	$ (1,128,779)	$ (3,412,754)	$ (829,564)
Adjustments to Reconcile Net loss to Net Cash Used in Operating Activities:
Issuance and amortization of common stock for services	1,122,322	112,268	276,792	237,833
Issuance of preferred stock for services	0	1,067	1,067	0
Fair value of warrants issued for services			51,488	0
(Gain) loss on settlement	58,893	355,000	(375,547)	0
Settlement fees paid in the form of debt	0	125,000	150,000	0
Amortization of prepaid shares issued for services			0	6,667
Other	0	100
Foreign currency transaction loss	(20,509)	0	31,548	0
Depreciation expense	340	0	81	538
Amortization of debt discount	1,224,235	117,231	295,795	49,029
Change in fair value of derivative liabilities	551,890	(122,742)	541,981	16,522
Accretion of put premium	755,927	165,428	1,044,196	27,187
Changes in Assets and Liabilities:
GST receivable	4,296	(1,226)	(10,879)	0
Prepaid expenses and other assets	(343,259)	0	(74,303)	294
Accounts payable	(118,305)	46,849	(47,977)	94,607
Employee benefit liability	12,447	3,915	20,362	11,598
Accrued expenses	(324,789)	46,585	115,941	158,847
Accrued interest	(10,005)	7,308	(34,270)	0
Other	(744)	0
NET CASH USED IN OPERATING ACTIVITIES	(1,488,222)	(271,996)	(1,426,479)	(226,442)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(676)	0	(3,901)	0
Payment for security deposit			(1,684)	0
NET CASH USED IN INVESTING ACTIVITIES	(676)	0	(5,585)	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Loan repayments to principal stockholder	(21,500)	(20,000)	(28,455)	(45,512)
Loan repayments	(23,852)	0
Proceeds from convertible promissory notes	2,977,500	90,000	1,438,500	273,959
Repayments of convertible promissory notes	(463,976)	0	(157,000)	0
Proceeds from issuance of common stock for cash	0	29,000	29,000	0
Bank overdraft			0	(6)
Loan proceeds			0	10,542
Loan proceeds from principal stockholder			0	72,158
NET CASH PROVIDED BY FINANCING ACTIVITIES	2,468,172	99,000	1,282,045	311,141
Effect of exchange rate changes on cash	81,217	99,785	169,847	3,100
NET INCREASE (DECREASE) IN CASH	1,060,491	(73,211)	19,828	87,799
CASH AT BEGINNING OF PERIOD	107,627	87,799	87,799	0
CASH AT END OF PERIOD	1,168,118	14,588	107,627	87,799
Cash paid during the period:
Interest	0	0	0	0
Income Tax	0	0	0	0
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Prepaid common stock issued for services	187,532	134,373	269,682	6,667
Reduction of put premium related to conversions of convertible note	636,348	37,032	71,370	0
Conversion of convertible notes and accrued interest to common stock	1,762,430	177,567	374,771	0
Discounts related to warrants issued with convertible debenture	1,619,075	0	0	133,095
Discounts related to lender costs	0	33,500	48,500	30,000
Discounts related to derivative liability	1,005,925	0	305,000	0
Conversion of loan payable to common stock	$ 0	$ 66,389	66,389	0
Common stock issued for settlement of debt			152,285	0
Prepaid warrants issued for services			138,314	0
Conversion of accrued expenses to common stock			0	27,500
Conversion of loan payable to convertible debenture			0	27,963
Prepaid settlement fee paid through issuance of convertible note			$ 0	$ 25,000

NATURE OF OPERATIONS AND SUMMAR

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Accounting Policies [Abstract]
NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES [Text Block]	NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and six months ended December 31, 2015 and 2014 and cash flows for the six months ended December 31, 2015 and 2014 and our financial position as of December 31, 2015 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2015. The June 30, 2015 balance sheet is derived from those statements. The unaudited consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statements of operations and other comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Other Comprehensive Income (Loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation gain 111,879 Ending balance, December 31, 2015 $ 212,847 The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of December 31, 2015 or June 30, 2015. Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status, or has been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted, or accepted in South Africa, Australia, and New Zealand. In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of December 31, 2015 and June 30, 2015 the Company was owed $ 6,808 ASC Topic 815, Derivatives and Hedging The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion. The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the six months ended December 31, 2015 and 2014 were $ 296,277 6,322 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”. In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the six months ended December 31 2015, there were 33,569,634 409,272,805 Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after December 31, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating or has implemented the following at December 31, 2015: In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2016. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs,"	NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. The consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates. The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statement of operations and comprehensive loss as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Comprehensive income (loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Currency Items: Beginning balance, June 30, 2013 $ (244,589) Foreign currency translation loss (58,274) Balance, June 30, 2014 (302,863) Foreign currency translation gain 403,831 Ending balance, June 30, 2015 $ 100,968 The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use. Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of June 30, 2015 or 2014. As amounts become uncollectible, they will be charged to an allowance and operations in the period when a determination of uncollectability is made. Any estimates of potentially uncollectible customer accounts receivable will be made based on an analysis of individual customer and historical write-off experience. The Company’s analysis included the age of the receivable account, creditworthiness of the customer and general economic conditions. Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value. The estimated useful lives are as follows: Machinery and equipment 5 Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status , or been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted , or accepted in South Africa, Australia, and New Zealand. In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. Liabilities arising in respect of wages and salaries, annual leave, accumulated sick leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured at their nominal amounts based on remuneration rates which are expected to be paid when the liability is settled. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months and therefore, recorded at nominal value. Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of June 30, 2015 and June 30, 2014 the Company was owed $ 11,647 946 ASC Topic 815, Derivatives and Hedging The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion. The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. Upon the adoption of ASC 740, the Company had no unrecognized tax benefits. During the years ended June 30, 2015 and 2014 no adjustments were recognized for uncertain tax benefits. The years 2008 through 2015 are subject to examination by the Australian Taxation Office. The years ended June 30, 2012 through 2015 is subject to examination by the United States Internal Revenue Service. In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the years ended June 30, 2015 and 2014 were $ 134,319 8,168 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. During the years ended June 30, 2015 and 2014, the Company applied for and received from the Australian Taxation Office a research and development tax credit in the amount of $ 77,470 48,267 The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”. In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition, In accordance with ASC 720-15-15, start-up costs are expensed as incurred. Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the years ended June 30 2015 and 2014, there were 7,379,158 3,000,000 335,716,597 6,069,667 Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after June 30, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company implemented the following at June 30, 2015: In June 2014, the FASB issued ASU No. 2014-10, which amended Accounting Standards Codification (ASC) Topic 915 Development Stage Entities. The amendment eliminates certain financial reporting requirements surrounding development stage entities, including an amendment to the variable interest entities guidance in ASC Topic 810, Consolidation. The amendment removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other entities from U.S. GAAP. Consequently, the amendment eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This amendment is effective for fiscal years beginning after December 15, 2014, and interim periods therein. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has made the election to early adopt this amendment effective June 30, 2014 and, as a result, the Company is no longer presenting or disclosing the information previously required under Topic 915. The early adoption was made to reduce data maintenance by removing all incremental financial reporting requirements for development stage entities. The adoption of this amendment alters the disclosure requirements of the Company, but it does not have any material impact on the Company's financial position or results of operations for the current or any prior reporting periods. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2015. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs,"

GOING CONCERN

GOING CONCERN	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Accounting Policies [Abstract]
Going Concern [Text Block]	NOTE 2 – GOING CONCERN The accompanying unaudited consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. For the six months ended December 31, 2015, the Company had no revenues and had a net loss of $ 4,400,961 1,488,222 3,361,141 3,355,864 25,366,632 The unaudited consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of this uncertainty. Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company's International patent application and achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared in conformity with US GAAP, which contemplate continuation of the Company as a going concern. For the year ended June 30, 2015, the Company had no revenues and had a net loss of $ 3,412,754 1,426,479 3,058,694 3,053,516 20,965,671 Successful completion of the Company’s development program and, ultimately, the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its development activities, acceptance of the Company's International patent application and achieving a level of sales adequate to support the Company’s cost structure. However, there can be no assurances that the Company will be able to secure additional equity investment or achieve an adequate sales level.

DUE TO DIRECTORS - RELATED PART

DUE TO DIRECTORS - RELATED PARTIES	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Due to Related Parties [Abstract]
Due To Directors Related Party [Text Block]	NOTE 3 – DUE TO DIRECTORS - RELATED PARTIES Due to directors - related parties represents unsecured advances made by the directors for operating expenses on behalf of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company are due upon demand. The Company is currently not being charged interest under these advances. The total amount owed these directors at December 31, 2015 and June 30, 2015 is $33,471 and $35,108 respectively.	NOTE 4 – DUE TO DIRECTORS - RELATED PARTIES Due to directors - related parties represents unsecured advances made by the directors for operating expenses on behalf of the Company such as intellectual property and formation expenses. The expenses were paid for on behalf of the Company and are due upon demand. The Company is currently not being charged interest under these advances. The total amount owed these directors at June 30, 2015 and June 30, 2014 is $ 35,108 60,350 44,000 44,000 14,000

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 3 – PROPERTY AND EQUIPMENT Property, plant, and equipment consist of the following as of June 30, 2015 2014 Office equipment at cost $ 15,732 $ 14,968 Less: Accumulated depreciation (12,238) (14,968) Total property, plant, and equipment $ 3,494 $ - Depreciation expense for the years ended June 30, 2015 and 2014 were $81 and $538 respectively.

LOANS AND NOTES PAYABLE

LOANS AND NOTES PAYABLE	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Notes and Loans Payable [Abstract]
Loans And Notes Payable Disclosure [Text Block]	NOTE 4 – LOANS Loans from Directors and Officer - Related Parties Loans from Directors and an Officer at December 31, 2015 and June 30, 2015 were $ 54,005 79,416 21,500 29,744 Other Loans from Unrelated Parties As of June 30, 2015, other loans from unrelated parties balance was $ 27,558 23,852 33,000 1,517 2,189	NOTE 5 – LOANS AND NOTES PAYABLE Loans from Directors and Officer - Related Parties Loans from Directors and an Officer at June 30, 2015 and June 30, 2014 were $ 79,416 161,975 127,000 109,000 33,259,350 17,654,470 27,000 14,000 0.0025 127,284 86,455 28,500 Other Loans from Unrelated Parties Loans from two unrelated parties were received during 2013 totaling $ 33,614 10 27,963 A loan from an unrelated party was received during the year ended June 30, 2014 totaling $ 9,419 10 A loan from an unrelated party was received during the year ended June 30, 2014 totaling $ 18,839 Accordingly, other loans totaled $ 33,909 In July 2014, the loans and notes payable balance of $ 33,909 27,558 Debt Settlement to be Paid in Stock, Net of Premium In July 2014, the Company consolidated outstanding debt and other liabilities as part of a settlement agreement (See Note 9) and was indebted to one unrelated party for approximately $ 1,033,000 50,000 355,000 628,000 7,426,000 8,161,000 81,396 575,000 310,000 50,000 17,000 Notes Payable On July 18, 2014, the Company paid a $ 50,000 50,000 10,000,000 50,000 25,000 1,466 0.0025 25,000 51,466

CONVERTIBLE NOTES

CONVERTIBLE NOTES	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 5 – CONVERTIBLE NOTES Convertible notes and debenture $ 3,630,024 Unamortized discounts (2,341,232) Accrued interest 82,802 Premium 577,925 Convertible notes, net $ 1,949,519 On August 6, 2014 (execution date), the Company executed a convertible promissory note in the principal sum of $250,000, with an original issue discount (“OID”) of $25,000. The consideration to be paid to the Lender shall be equal to the consideration actually paid by the Lender plus prorated interest and any other fees that the Company shall be required to pay. The original issue discount shall also be prorated based on the actual consideration received to equal approximately 10% of the consideration received. If the Company repays a consideration payment on or before the first 90 days from the effective date of that payment, the interest rate on that payment of consideration will be 0%. If the Company does not repay a payment on or before the 90 days, the Company will incur a one-time interest charge of 12% on the principal amount of the loan. Upon execution of the note, the note holder made an initial payment of $25,000 (net of a $2,500 OID) to the Company of the total consideration. The maturity date is two years from the date of each payment to the Company, and is the date upon which the principal sum, as well as any unpaid interest and other fees, shall be due and payable. The note is convertible, at the option of the investor, to common stock of the Company at any time after the effective date at the lesser of $0.09 or 60% of the lowest trade price in the 25 trading days prior to the conversion. The Company didn’t repay the consideration payment on or before the first 90 days from the effective date of that payment and therefore incurred a 12% interest charge. No further funding other than the above mentioned $ 25,000 250,000 90,000 27,500 3,607 58,893 On February 10, 2015, the Company issued a convertible note payable for $45,000 with an OID of $7,500. The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is February 10, 2016. The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days prior to the date upon which the conversion notice was received. 9,409 27,409 45,000 1,887 36,818 On February 17, 2015, the Company issued a second convertible note payable for $45,000 with an OID of $7,500. The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is February 17, 2016. The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days prior to the date upon which the conversion notice was received. 9,409 27,409 45,000 2,229 36,818 On March 12, 2015, the Company issued a third convertible note payable for $170,500 with an OID of $13,000. The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is March 12, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the Company’s common stock for the average of the lowest three trading prices in the ten prior trading days including the date upon which the conversion notice was received. 170,500 8,580 139,500 On March 20, 2015, the Company issued a fourth convertible note payable for $150,000. The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is March 20, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the lowest trading bid price of the Company’s common stock for the average of the lowest three trading priced in the ten prior trading days including the date upon which the conversion notice was received. 150,000 9,436 122,727 In addition to each of the above initial convertible promissory notes (“initial convertible notes”), the Company issued to each lender another convertible promissory note for the same amounts of $45,000, $45,000, $170,500 and $150,000 termed "Back-End Notes". These notes have the same terms as the initial convertible notes. Each Back-End Note shall initially be paid for by an offsetting promissory note issued to the Company by the lender ("Note Receivable") provided that prior to the conversion of the Back-End Notes, the holders must have paid off the Notes Receivable in cash. Each Note Receivable is due eight months from issuance of each initial convertible note, unless the Company does not meet the “current public information” requirement pursuant to Rule 144, in which case both the Back-End Notes and the Notes Receivable may both be cancelled. Each Note Receivable is initially secured by the pledge of the Back-End Notes, but may be exchanged for other collateral with an appraised value of at least the principal amount of the note less the OID, upon Company’s approval following a three (3) day written notice to the Company. The term of the Notes Receivable and the Back-End Notes are one year, upon which the outstanding principal and interest is payable. The amounts funded plus accrued interest under Back-End Notes are convertible into common stock at any time after the requisite Rule 144 holding period (subject to the condition above for the Back-End Notes), at a conversion price equal to 55 In the event the Company redeems the initial convertible notes in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by i) 130% if prepaid within 60 days of the issuance date; ii) 140% if prepaid 60 but less than 121 days after the issuance date; and (iii) 150% if prepaid 120 but less than 180 days after the issuance date. There shall be no redemption after the 180th day. The Back-End Notes may not be prepaid, except that if the initial convertible notes are redeemed by the Company within six months of their issuance, all obligations of the Company and holders under the Back-End Notes and the Notes Receivable will be deemed satisfied and such notes shall automatically be deemed cancelled and of no further force or effect. In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24% per annum, or the highest rate of interest permitted by law. On February 15, 2015, in connection with a six-month consulting agreement, the Company issued a convertible promissory note for $90,000 as compensation for services to be rendered. The Company agreed to pay 5% interest per annum on the principal amount and the maturity date is August 15, 2015. The note is convertible at the option of the holder at any time after issuance of note at a rate of 60% of the lowest trading price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company fully expensed a $60,000 put premium. During the six months ended December 31, 2015, the Company converted $ 85,000 56,667 2,764 On March 12, 2015, the Company issued a convertible promissory note for $104,000. The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is December 16, 2015. The note is convertible at the option of the holder at any time after 180 days at a rate of 58% of the average lowest three trading closing bid prices of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company is accreting a $75,310 put premium over 180 days from the execution of the convertible note. On July 15, 2015, the Company repaid cash of $137,915 as payment in full of $104,000 of principal and accrued interest of $2,872 resulting in $31,043 of a prepayment penalty which was expensed as interest expense. During the six months ended December 31, 2015, the Company has accreted $ 6,276 46,441 22,593 On March 12, 2015, in connection with a two-year consulting agreement, the Company issued a convertible promissory note for $60,000 as compensation for services to be rendered. The Company agreed to pay 10% interest per annum on the principal amount and the maturity date is March 11, 2017. The note is convertible, at the option of the holder, at any time after the effective date at the lesser of $0.0175 or 75% of the volume weighted average of the lowest three trading closing bid prices of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. This note was bifurcated with the embedded conversion option recorded as a derivative liability at fair value (See Note 10). Accrued interest as of December 31, 2015 was $ 4,849 On April 20, 2015, the Company issued a convertible note payable for $17,500. The Company agreed to pay 8% interest per annum on the principal amount and the maturity date is April 20, 2016. The note is convertible at the option of the holder at any time at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company recognized a $14,318 put premium. During the six months ended December 31, 2015, the Company converted $ 16,500 803 13,500 59 On April 24, 2015, the Company received payment of the Note Receivable of $45,000, less the OID of $7,500, that offsets the Back-End Note that was issued on February 10, 2015. Proceeds from the Note Receivable of $2,250 were paid directly to legal fees resulting in net cash proceeds of $35,250 received by the Company. This Back-End Note is related to the initial convertible note that was issued on February 10, 2015 and has the same terms as previously discussed. As a result, the Back-End Note is now eligible for conversion at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company is accreting a $36,818 put premium over 180 days from the execution of the convertible note. During the six months ended December 31, 2015, the Company has accreted the remaining $ 22,909 13,909 45,000 1,765 36,818 On April 24, 2015, the Company received payment of the Note Receivable of $45,000, less the OID of $7,500, that offsets the Back-End Note that was issued on February 17, 2015. Proceeds from the Note Receivable of $2,250 were paid directly to legal fees resulting in net cash proceeds of $35,250 received by the Company. This Back-End Note is related to the initial convertible note that was issued on February 17, 2015 and has the same terms as previously discussed. As a result, the Back-End Note is now eligible for conversion at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company is accreting a $36,818 put premium over 180 days from the execution of the convertible note. During the six months ended December 31, 2015, the Company has accreted the remaining $ 22,909 13,909 1,000 46 818 2,430 On April 27, 2015, the Company received payment of the Note Receivable of $170,500, less the OID of $13,000, that offsets the Back-End Note that was issued on March 12, 2015. Proceeds from the Note Receivable of $7,500 were paid directly to legal fees resulting in net cash proceeds of $150,000 received by the Company. This Back-End Note is related to the initial convertible note that was issued on March 12, 2015 and has the same terms as previously discussed. As a result, the Back-End Note is now eligible for conversion at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company recognized a $139,500 put premium. During the six months ended December 31, 2015, the Company converted $ 170,500 8,303 139,500 On May 19, 2015, the Company entered into a Securities Purchase Agreement (“SPA”), to issue a series of nine back end convertible notes in the principal sum of $782,500, pursuant to the SPA, the Company issued to the lender nine convertible promissory notes termed "Back-End Notes", in the amounts of $37,500 ("Back-End Note 1"), $37,500 ("Back-End Note 2"), $157,500 ("Back-End Note 3"), $150,000 ("Back-End Note 4"), $17,500 ("Back-End Note 5"), $37,500 ("Back-End Note 6"), $37,500 ("Back-End Note 7"), $157,500 ("Back-End Note 8") and $150,000 ("Back-End Note 9"). These notes have the same terms as the initial convertible notes. Each Back-End Note shall initially be paid for by an offsetting promissory note issued to the Company by the lender ("Note Receivable") provided that prior to the conversion of the Back-End Notes, the holders must have paid off the Notes Receivable in cash. Each Note Receivable is due on May 19, 2016, unless the Company does not meet the “current public information” requirement pursuant to Rule 144, in which case both the Back-End Notes and the Notes Receivable may both be cancelled. Each Note Receivable is initially secured by the pledge of the Back-End Notes, but may be exchanged for other collateral with an appraised value of at least the principal amount of the note less the OID, upon Company’s approval following a three (3) day written notice to the Company. The term of the Notes Receivable and the Back-End Notes are one year, upon which the outstanding principal and interest is payable. The amounts funded plus accrued interest under Back-End Notes are convertible into common stock at any time after the requisite Rule 144 holding period (subject to the condition above for the Back-End Notes), at a conversion price equal to 55% of the lowest trading bid price in the ten (10) trading days prior to the conversion. During the six months ended December 31, 2015, all of the Back-End Notes (an aggregate total principal of $ 782,500 The Back-End Notes may not be prepaid, except that if the initial convertible notes are redeemed by the Company within six months of their issuance, all obligations of the Company and holders under the Back-End Notes and the Notes Receivable will be deemed satisfied and such notes shall automatically be deemed cancelled and of no further force or effect. In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24% per annum, or the highest rate of interest permitted by law. Since the Back-End Notes are not convertible until the Notes Receivable are paid, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On June 2, 2015, the Company received payment of the Note Receivable of $150,000 that offsets the Back-End Note that was issued on March 20, 2015. Proceeds from the Note Receivable of $7,500 were paid directly to legal fees resulting in net cash proceeds of $142,500 received by the Company. This Back-End Note is related to the initial convertible note that was issued on March 20, 2015 and has the same terms as previously discussed. As a result, the Back-End Note is now eligible for conversion at a rate of 55% of the lowest trading bid price of the Company’s common stock for the ten prior trading days including the date upon which the conversion notice was received. The convertible note is treated as stock settled debt under ASC 480 and accordingly the Company recognized a $122,727 put premium. During the six months ended December 31, 2015, the Company converted $ 45,000 2,140 36,818 5,740 On June 4, 2015 (execution date), the Company executed a convertible promissory note in the principal sum of $1,215,000, with an OID of $110,000. The consideration to be paid to the lender shall be equal to the consideration actually paid by the lender plus prorated interest and any other fees that the Company shall be required to pay. The original issue discount shall also be prorated based on the actual consideration received to equal approximately 10% of the consideration received. The Company agreed to pay 10% interest per annum on the principal amount and the maturity date is ten months from the date of each payment to the Company, and is the date upon which the principal sum, as well as any unpaid interest and other fees, shall be due and payable. The note is comprised of an initial cash purchase of $335,000 (includes $30,000 of OID and $5,000 for legal fees) (“Initial Note”), a Secured Investor Note of $220,000 (includes $20,000 of OID) (“Secured Investor Note”) and three Investor Notes of $220,000 each (include $20,000 of OID each) (“Investor Notes”). The Secured Investor Note is secured by the lender’s 40% membership interest in a certain LLC. The Company will accrue 10% interest per annum on the unpaid principal amount of the Secured Investor Note and the three Investor Notes as defined in the agreements. Upon execution of the note, the note holder made an initial cash payment of $300,000 (net of a $30,000 OID and $5,000 for legal fees) to the Company of the total consideration and issued the Secured Investor Note and three Investor Notes to the Company. On July 13, 2015, the Company received payment of the Secured Investor Note of $ 220,000 20,000 1,997 201,997 269,976 29,468 On July 14, 2015, the Company received payment of three Note Receivables of $ 352,500 17,690 334,810 288,409 288,409 20,000 690 16,364 12,308 On October 1, 2015, the Company received cash of $ 1,150,000 50,000 th On October 14, 2015 and October 15, 2015, the Company received payment of six Note Receivables of $ 430,000 22,265 407,735 55 351,818 179,818 7,339 On October 28, 2015 (the “Closing Date”), the Company entered into a securities purchase agreement dated as of the Closing Date (the “Purchase Agreement”) with a third party purchaser (the “Purchaser”). The Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, the Purchaser will invest $4,000,000 (“Investment Amount”) in exchange for a Convertible Debenture (the “Debenture”) in the principal amount of $ 4,400,000 26,190,476 0.001 0.60 Under the terms of the Purchase Agreement, the Purchaser agreed to deliver the Promissory Note entered into by the Company and Purchaser on September 24, 2015 with a principal amount of $ 1,200,000 Under the terms of the Purchase Agreement and Debenture, $ 2,800,000 25,000 25,000 50,000 The Purchase Agreement contains customary representations, warranties and covenants by, among and for the benefit of the parties. The Company also agreed to pay up to $50,000 of reasonable attorneys’ fees and expenses incurred by the Purchaser in connection with the transaction. The Purchase Agreement also provides for indemnification of the Purchaser and its affiliates in the event that the Purchaser incurs losses, liabilities, obligations, claims, contingencies, damages, costs and expenses related to a breach by the Company of any of its representations, warranties or covenants under the Purchase Agreement. The Debenture has a 10 5 The Debenture includes customary event of default provisions, and provides for a default interest rate of 18 Subject to the conditions set forth in the Debenture, the Company has the right at any time to redeem some or all of the total outstanding amount then remaining under the Debenture in cash at a price equal to 125% of the total amount of the Debenture outstanding on the twentieth (20th) trading date following the date the Company delivers notice of such redemption to the Purchaser. The Warrants are exercisable in whole or in part, at an initial exercise price per share of $ 0.60 In connection with the execution of the Purchase Agreement, on the Closing Date, the Company and the Purchaser also entered into a registration rights agreement dated as of the Closing Date (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Company has agreed to file an initial registration statement (“Registration Statement”) with the SEC to register the resale of the Common Stock into which the Debenture may be converted or the Warrant may be exercised, within 30 days following the Closing Date. The Registration Statement must also be declared effective by the 100th calendar day after the Closing Date, subject to a 20-day extension as requested by the Company and consented to by the Purchaser. On November 23, 2015, the Company filed a registration statement with the SEC and on December 10, 2015, the registration statement was deemed effective. If at any time all of the shares of Common Stock underlying the Debenture or the Warrant are not covered by the initial Registration Statement, the Company has agreed to file with the SEC one or more additional Registration Statements so as to cover all of the shares of Common Stock underlying the Debenture or the Warrant not covered by such initial Registration Statement, in each case, as soon as practicable, but in no event later than the applicable filing deadline for such additional Registration Statements as provided in the Registration Rights Agreement. In connection with the Purchase Agreement, the Company entered into a Security Agreement dated as of even date therewith with the Purchaser whereby the Company agreed to grant to Purchaser an unconditional and continuing, first priority security interest in all of the assets and property of the Company to secure the prompt payment, performance and discharge in full of all of Company’s obligations under the Debentures, Warrants and the other transaction documents until ten days following the such time as the Registration Statement is declared effective by the SEC and the equity conditions set forth in the Debenture are met. The Company recorded $ 2,887,500 63,500 961,735 23,970	NOTE 6 – CONVERTIBLE NOTES June 30, 2015 June 30, 2014 Convertible notes and debenture $ 1,455,000 $ 366,296 Unamortized discounts (415,467) (121,059) Accrued interest 26,989 - Premium, net 727,853 27,187 Convertible notes, net $ 1,794,375 $ 272,424 On September 30, 2013 the Company’s subsidiary issued a Debenture for $ 139,680 150,000 3,000,000 12 27,963 63,196 46,446 0.075 0.0698 0.20 0.075 53 27 0.4 400,000 140,000 260,000 139,680 15,118 0.0709 0.075 2,183,333 On May 8, 2014, the Company issued a 10 25,000 25,000 25,000 1,466 On May 29, 2014, the Company issued a convertible note payable for $ 75,000 8 May 29, 2015 180 55 61,364 180 51,089 10,275 14,547 218 61,364 60,453 4,352 On May 29, 2014, the Company issued a second convertible note payable for $ 75,000 8 May 29, 2015 55 61,364 51,089 10,275 11,755 553 61,364 63,245 3,313 On May 30, 2014, the Company issued a third convertible note payable for $ 50,000 8 May 30, 2015 180 55 40,909 34,273 6,636 50,000 3,346 40,909 In addition to each of the above initial convertible promissory notes (“initial convertible notes”), the Company issued to each lender another convertible promissory note for the same amounts of $ 75,000 75,000 50,000 In the event the Company redeems the initial convertible notes in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by i) 130 140 150 In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 16 Since the Back-End Notes are not convertible until the Notes Receivable are paid and also not for 180 days from the note dates, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On August 6, 2014 (execution date), the Company executed a convertible promissory note in the principal sum of $ 250,000 25,000 10 0 12 0.09 60 12 2,134 250,000 On November 17, 2014, the Company issued a convertible promissory note for $ 43,000 8 August 20, 2015 180 58 31,138 27,851 61,632 43,000 1,527 17,105 3,287 On December 10, 2014, the Company issued a convertible promissory note for $ 28,000 8 September 12, 2015 180 58 20,276 15,657 38,654 28,000 853 9,801 4,619 On January 26, 2015, the Company issued a convertible promissory note for $ 28,000 8 October 28, 2015 180 58 20,276 15,432 37,137 28,000 835 8,302 4,844 On January 27, 2015, the Company received payment of the Note Receivable of $ 50,000 7,779 2,500 5,000 34,721 55 40,909 180 40,909 50,000 609 40,909 On February 10, 2015, the Company issued a convertible note payable for $ 45,000 7,500 8 February 10, 2016 180 55 36,818 27,409 1,391 On February 17, 2015, the Company issued a second convertible note payable for $ 45,000 7,500 8 February 17, 2016 180 55 36,818 27,409 1,322 On March 12, 2015, the Company issued a third convertible note payable for $ 170,500 13,000 8 March 12, 2016 55 139,500 4,148 On March 20, 2015, the Company issued a fourth convertible note payable for $ 150,000 8 March 20, 2016 55 122,727 3,386 In addition to each of the above initial convertible promissory notes (“initial convertible notes”), the Company issued to each lender another convertible promissory note for the same amounts of $ 45,000 45,000 170,500 150,000 In the event the Company redeems the initial convertible notes in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by i) 130 140 150 In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24 Since the Back-End Notes are not convertible until the Notes Receivable are paid and also not for 180 days from the note dates, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On February 15, 2015, in connection with a six-month consulting agreement, the Company issued a convertible promissory note for $ 90,000 5 August 15, 2015 60 60,000 1,677 On February 20, 2015, the Company issued a convertible promissory note for $ 58,000 12 July 27, 2015 180 50 58,000 36,411 83,512 58,000 2,212 23,300 21,589 On March 12, 2015, the Company issued a convertible promissory note for $ 104,000 8 December 16, 2015 180 58 75,310 46,441 2,530 137,915 104,000 2,872 (See Note 13) On March 12, 2015, in connection with a two-year consulting agreement, the Company issued a convertible promissory note for $ 60,000 10 March 11, 2017 0.0175 75 1,825 On April 20, 2015, the Company issued a convertible note payable for $ 17,500 8 April 20, 2016 55 14,318 272 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 2,250 35,250 55 36,818 180 13,909 671 On April 24, 2015, the Company received payment of the Note Receivable of $ 45,000 7,500 2,250 35,250 55 36,818 180 13,909 671 On April 27, 2015, the Company received payment of the Note Receivable of $ 170,500 13,000 7,500 150,000 55 139,500 2,429 On May 19, 2015, the Company entered into a Securities Purchase Agreement (“SPA”), to issue a series of nine back end convertible notes in the principal sum of $ 782,500 37,500 37,500 157,500 150,000 17,500 37,500 37,500 157,500 150,000 55 The Back-End Notes may not be prepaid, except that if the initial convertible notes are redeemed by the Company within six months of their issuance, all obligations of the Company and holders under the Back-End Notes and the Notes Receivable will be deemed satisfied and such notes shall automatically be deemed cancelled and of no further force or effect. In the event of two specific defaults, which include the maintenance of a minimum trading price and an aggregate dollar trading volume of the Company's common shares, the holders may cancel the Back-End Notes and the related Notes Receivable and otherwise in the event of other defaults as defined in the securities purchase agreement, the amount of principal and accrued interest will become immediately due and payable and may be offset by amounts due to the Company by the holders. Additionally, the Back-End Notes will bear default interest at a rate of 24% per annum, or the highest rate of interest permitted by law. Since the Back-End Notes are not convertible until the Notes Receivable are paid, and the Notes Receivable and Back-End Notes have a right of setoff, the Notes Receivable and Back-End Notes and related accrued interest receivable and payable have been netted for presentation purposes on the accompanying consolidated balance sheet. On June 2, 2015, the Company received payment of the Note Receivable of $ 150,000 7,500 142,500 55 122,727 2,137 On June 4, 2015 (execution date), the Company executed a convertible promissory note in the principal sum of $ 1,215,000 110,000 10 335,000 30,000 5,000 220,000 20,000 220,000 20,000 40 10 300,000 30,000 5,000 0.07 3,000,000 2,513 The Company recorded $ 529,500 30,000 114,033 3,133

INCOME TAXES

INCOME TAXES	12 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 7 – INCOME TAXES The Company follows ASC 740-10-10, under which an entity recognizes deferred tax assets and liabilities for future tax consequences or for events that were previously recognized in the Company’s financial statements or tax returns. The measurement of deferred tax assets and liabilities is based on enacted tax law provisions. The effects of future changes in tax laws or rates are not anticipated. As of June 30, 2015, the Company operated exclusively in Australia. The Company was wholly subject to Australia income tax laws and regulations, which are administered by the Australian Taxation Office for the years ended June 30, 2015 and 2014 and all prior years. On November 23, 2010, Propanc Health Group Corporation was incorporated in the state of Delaware. In January 2011, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary. As a result of these transactions, the Company is subject to the income tax laws of both the United States and Australia for the years ended June 30, 2015 and 2014. For the years ended June 30, 2015 and 2014, all the Company’s loss before income taxes resulted entirely from its Australian activities and its taxable loss was only subject to Australian tax law. At June 30, 2015, the Company has a net operating loss (NOL) for Australian tax purposes only, that approximates $ 12,486,000 1,527,228 Year Ended June 30, June 30, 2015 2014 Current Taxes $ (77,470) $ (48,267) Deferred Taxes - - Income Taxes Expense (Benefit) $ (77,470) $ (48,267) Year Ended June 30, June 30, 2015 2014 Impact on Impact on Amount Rate Amount Rate Income Tax Expense (Benefit) at Australia Statutory Rate $ (672,087) (19.26) % $ (274,229) (31.24) % Expenses Paid by Parent on Behalf of Foreign Subsidiary 156,410 4.48 % 92,480 10.54 % R&D Refundable Tax Credit (77,470) (2.22) % (48,267) (5.50) % Reduction of NOL Carryforward Due to R&D Tax Credit 77,470 2.22 % 48,267 5.50 % Change in Deferred Tax Valuation Allowance (355,636) (10.19) % 260,533 29.68 % Foreign Exchange Rate Changes 793,843 22.74 % (127,051) (14.47) % Total Income Tax Expense (Benefit) $ (77,470) (2.22) % $ (48,267) (5.50) % Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. June 30, June 30, 2015 2014 Current Deferred Tax Assets Warrant Derivative Liability $ 88,204 $ 28,209 Provision for Annual Leave 21,426 18,848 Superannuation - 3,815 Total Current Deferred Tax Assets $ 109,630 $ 50,872 Current Deferred Tax Liabilities Prepaid Investor Services $ - $ - Prepaid Expenses - - Prepaid Insurance - - Accounts Payable/Trade Creditors - - Patent Costs - - Total Current Deferred Tax Liabilities $ - $ - Non-Current Deferred Tax Assets Prepaid Investor Services $ 185,025 $ 751,917 Capital Raising Costs 23,261 28,622 Legal Costs 23,583 29,019 Intellectual Property 11,612 14,288 Patent Costs 59,995 59,473 Formation Expense 7,117 8,757 Net Operating Loss Carryover 3,426,149 3,259,060 Foreign Exchange Loss (OCI) (30,290) 90,859 Total Non-Current Deferred Tax Assets 3,706,452 4,241,995 Deferred Tax Valuation Allowance (3,816,082) (4,292,867) Total Non-Current Deferred Tax Assets (109,630) (50,872) Total Deferred Tax Assets (Net) $ - $ - Management has determined that the realization of the net deferred tax asset is not assured and has created a valuation allowance for the entire amount of such benefits. The Company follows ASC 740-10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition involves a determination whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information. The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of June 30, 2015 the Company had no unrecognized tax benefits. There were no changes in the Company’s unrecognized tax benefits during the years ended June 30, 2015 and 2014. The Company did not recognize any interest or penalties during fiscal 2015 or 2014 related to unrecognized tax benefits. The income tax returns filed for the tax years from inception will be subject to examination by the relevant taxing authorities.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 6 – STOCKHOLDERS’ DEFICIT Preferred Stock: The total number of preferred shares authorized and that may be issued by the Company is 10,000,000 0.01 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on December 9, 2014, 500,000 0.01 500,000 0.00213 1,067 8,161,000 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on June 16, 2015, up to five (5) shares have been designated as Series B preferred stock, with a par value of $ 0.01 0.1165 0.12 Common Stock: On November 12, 2014, the Company filed an amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware, to increase the Company’s authorized common stock from one hundred million (100,000,000) 0.001 (10,000,000,000) 0.001 (10,000,000,000) 0.001 (2,000,000,000) 0.001 Shares issued for services On June 4, 2015, the Company entered into an agreement with a consultant to provide services over a six month period in exchange for 500,000 500,000 0.0706 35,300 500,000 30,285 On August 26, 2015, the Company issued 560,000 560,000 0.04 15,461 On September 8, 2015, the Company issued 600,000 600,000 0.0369 22,140 Additionally, during the six months ended December 31, 2015, the Company recognized $ 407,581 On July 24, 2015, the Company entered into an agreement with a consultant to provide services over a six month period. The Company agreed to issue the consultant 8,000,000 8,000,000 0.0435 348,000 8,000,000 299,246 On October 1, 2015, the Company entered into an agreement with a consultant to provide services over a one year period. The Company agreed to issue the consultant 1,500,000 1,500,000 1,500,000 0.031 46,500 11,720 1,100,000 400,000 On October 16, 2015, the Company issued 4,000,000 4,000,000 0.0415 166,000 68,940 On December 30, 2015, the Company entered into an agreement with a consultant to provide services over a nine month period. The Company agreed to issue the consultant 1,000,000 1,000,000 0.0260 26,000 1,000,000 189 Shares issued for conversion of convertible debt On August 14, 2015, pursuant to a conversion notice, $ 20,500 0.02365 866,796 On August 14, 2015, pursuant to a conversion notice, $ 20,802 0.02365 879,585 On August 26, 2015, pursuant to a conversion notice, $ 26,068 0.018425 1,414,843 On September 1, 2015, pursuant to a conversion notice, $ 25,723 0.018425 1,396,108 On September 4, 2015, pursuant to a conversion notice, $ 15,648 0.018425 849,263 On September 16, 2015, pursuant to a conversion notice, $ 15,687 0.018975 826,726 On September 18, 2015, pursuant to a conversion notice, $ 15,694 0.017875 877,969 On September 22, 2015, pursuant to a conversion notice, $ 15,638 0.01716 911,294 On October 1, 2015, pursuant to a conversion notice, $ 26,635 0.012375 2,152,289 On October 7, 2015, pursuant to a conversion notice, $ 31,374 0.012375 2,535,293 On October 13, 2015, pursuant to a conversion notice, $ 109,004 0.012375 8,808,435 On October 13, 2015, pursuant to a conversion notice, $ 104,712 0.012375 8,461,602 On October 15, 2015, pursuant to a conversion notice, $ 50,000 0.01 5,000,000 On November 17, 2015, pursuant to a conversion notice, $ 2,099 0.01986 105,709 On November 17, 2015, pursuant to a conversion notice, $ 35,000 0.01 3,500,000 On November 23, 2015, pursuant to a conversion notice, $ 15,707 0.0154 1,019,925 On November 24, 2015, pursuant to a conversion notice, $ 20,947 0.0154 1,360,185 On November 30, 2015, pursuant to a conversion notice, $ 49,287 0.0154 3,200,448 On December 4, 2015, pursuant to a conversion notice, $ 31,703 0.0154 2,058,637 On December 8, 2015, pursuant to a conversion notice, $ 63,213 0.01595 3,963,207 On December 11, 2015, pursuant to a conversion notice, $ 50,000 0.02608 1,917,178 On December 15, 2015, pursuant to a conversion notice, $ 50,000 0.02712 1,843,658 On December 16, 2015, pursuant to a conversion notice, $ 31,782 0.01650 1,926,177 On December 17, 2015, pursuant to a conversion notice, $ 40,000 0.02500 1,600,000 On December 21, 2015, pursuant to a conversion notice, $ 40,000 0.02360 1,694,916 On December 21, 2015, pursuant to a conversion notice, $ 51,719 0.01584 3,265,069 On December 23, 2015, pursuant to a conversion notice, $ 40,000 0.02320 1,724,138 On December 23, 2015, pursuant to a conversion notice, $ 31,414 0.01584 1,983,188 On December 28, 2015, pursuant to a conversion notice, $ 40,000 0.02320 1,724,138 On December 29, 2015, pursuant to a conversion notice, $ 15,727 0.01573 999,783 On December 30, 2015, pursuant to a conversion notice, $ 40,000 0.02284 1,751,314 Warrants: On October 28, 2015, pursuant to a convertible debenture, the Company issued 26,190,476 0.60 4 As of December 31, 2015, there were 33,569,634	NOTE 8 – STOCKHOLDERS’ DEFICIT Preferred Stock: The total number of preferred shares authorized and that may be issued by the Company is 10,000,000 0.01 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on December 9, 2014, 500,000 0.01 500,000 0.00213 1,067 8,161,000 Of the total preferred shares authorized, pursuant to Certificate of Designation filed on June 16, 2015, up to five (5) shares have been designated as Series B preferred stock, with a par value of $ 0.01 0.1165 0.12 This value represents the economic rights of the share as the value of voting rights, which represent control rights, are not objectively measureable. Common Stock: On November 12, 2014, the Company filed an amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware, to increase the Company’s authorized common stock from one hundred million (100,000,000) shares of common stock, par value $ 0.001 0.001 0.001 0.001 In July 2013, the Company issued 300,000 0.20 12,000 48,000 In July 2013, the Company issued 250,000 0.20 50,000 In July 2013, the Company issued 137,500 27,500 0.20 In July 2013, the Company issued 10,000 0.20 2,000 In July 2013, the Company issued 150,000 0.20 30,000 In September 2013, the Company issued the balance of 300,000 0.20 60,000 On September 30, 2013, pursuant to a consulting agreement, the company issued 25,000 0.20 5,000 In October 2013, the Company issued 500,000 0.10 50,000 In October 2013, the Company issued 200,000 0.10 13,333 6,667 In October 2013, the Company issued 100,000 0.10 10,000 In November 2013, the Company issued 30,000 0.10 3,000 In November 2013, the Company issued 25,000 0.10 2,500 On May 9, 2014, the Company entered into an agreement with a consultant to provide services over a twelve month period in exchange for 1,000,000 0.10 100,000 500,000 500,000 100,000 On July 2, 2014, a $ 139,680 154,798 0.0709 2,183,333 On September 11, 2014, the Company issued 7,426,000 On October 17, 2014, the Company entered into an agreement with a consultant to provide services over a six month period. The Company agreed to issue the consultant 4,000,000 3,000,000 3,000,000 10,000,000 0.008 80,000 4,000,000 6,000,000 80,000 On November 4, 2014, the Company issued 8,161,000 On November 5, 2014, the Company entered into a private placement securities purchase agreement with an accredited investor pursuant to which the Company agreed to issue up to 3,000,000 0.001 3,000 3,000,000 On December 9, 2014, pursuant to a conversion notice, $ 5,357 0.0011 4,870,391 On December 10, 2014, pursuant to a conversion notice, $ 7,368 0.0011 6,698,331 On December 11, 2014, the Company entered into a private placement securities purchase agreement with an accredited investor pursuant to which the Company agreed to issue up to 1,000,000 0.0025 2,500 On December 16, 2014, the Company entered into a private placement securities purchase agreements with accredited investors pursuant to which the Company agreed to issue up to 9,400,000 0.0025 23,500 On December 16, 2014, pursuant to a conversion notice, $ 6,000 0.0012 5,194,805 On December 24, 2014, pursuant to a conversion notice, $ 3,762 0.0007 5,700,000 On December 26, 2014, pursuant to a conversion notice, $ 4,044 0.0007 5,655,958 During the year ended June 30, 2015, pursuant to the January 30, 2015 Settlement and Lock-up Agreement (Note 9), the Company issued 10,000,000 0.0025 25,000 On February 2, 2015, pursuant to a conversion notice, $ 3,446 0.0006 6,265,964 On February 4, 2015, pursuant to debt settlement agreements with two directors (Note 4), the Company issued 17,654,470 33,259,350 0.0025 44,136 83,148 On February 9, 2015, pursuant to a conversion notice, $ 21,100 0.0035 6,089,544 On February 17, 2015, pursuant to a conversion notice, $ 3,266 0.0006 5,937,563 On February 17, 2015, pursuant to a conversion notice, $ 15,323 0.0035 4,422,257 On March 6, 2015, pursuant to a conversion notice, $ 3,410 0.0006 6,200,000 On March 6, 2015, pursuant to a conversion notice, $ 6,443 0.0015 4,338,384 On March 6, 2015, pursuant to a conversion notice, $ 1,011 0.0015 680,485 On March 11, 2015, pursuant to a conversion notice, $ 14,675 0.0015 9,882,013 On March 11, 2015, pursuant to a conversion notice, $ 10,121 0.0015 6,815,185 On March 12, 2015, pursuant to a conversion notice, $ 1,001 0.0015 674,141 On March 12, 2015, pursuant to a conversion notice, $ 14,678 0.0015 9,884,155 On March 12, 2015, pursuant to a conversion notice, $ 10,125 0.0016 6,347,918 On March 16, 2015, pursuant to a conversion notice, $ 15,534 0.0017 9,110,833 On March 17, 2015, pursuant to a conversion notice, $ 1,061 0.0017 622,504 On March 17, 2015, pursuant to a conversion notice, $ 20,048 0.0019 10,414,660 On March 18, 2015, pursuant to a conversion notice, $ 20,053 0.0020 10,127,576 On March 19, 2015, pursuant to a conversion notice, $ 8,260 0.0020 4,171,808 On March 20, 2015, pursuant to a conversion notice, $ 23,762 0.0020 12,001,242 On April 14, 2015, pursuant to a conversion notice, $ 4,271 0.0020 2,135,450 On April 15, 2015, pursuant to a conversion notice, $ 10,145 0.0020 5,072,740 On April 21, 2015, pursuant to a conversion notice, $ 28,202 0.0020 14,100,870 On May 7, 2015, the Company entered into an agreement with a consultant to provide services over a six month period in exchange for 6,758,316 shares of common stock. The Company valued the 6,758,316 0.043 290,608 6,758,316 88,446 On May 21, 2015, the Company entered into an agreement with a consultant to provide services over an eight month period in exchange for 1,000,000 shares of common stock. The Company valued the 1,000,000 0.0445 44,500 1,000,000 7,265 On June 4, 2015, the Company entered into an agreement with a consultant to provide services over a six month period in exchange for 500,000 shares of common stock. The Company valued the 500,000 0.0706 35,300 500,000 5,015 Warrants: In September, 2013, pursuant to convertible debenture, the Company issued 3,000,000 0.0698 5 In connection with above agreement dated May 7, 2015, the Company issued to the consultant, warrants for 3,379,158 0.043 0.03 397 60 1.54 145,303 101,080 44,223 In connection with above agreement dated May 21, 2015, the Company issued to the consultant warrants for 1,000,000 0.0445 0.07 397 60 1.54 44,500 37,235 7,265 As of June 30, 2015, there were 7,379,158 Weighted Number of Average Shares Price Per Share Outstanding at June 30, 2013 - $ - Issued 3,000,000 0.07 Exercised - - Expired - - Outstanding at June 30, 2014 3,000,000 0.07 Issued 4,379,158 0.04 Exercised - - Expired - - Outstanding at June 30, 2015 7,379,158 $ 0.05 Exercisable at June 30, 2015 7,379,158 $ 0.05 Outstanding and Exercisable: Weighted average remaining contractual term 4.21 Aggregate intrinsic value $ 319,774

COMMITMENTS AND CONTINGIENCIES

COMMITMENTS AND CONTINGIENCIES	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 7 – COMMITMENTS AND CONTINGIENCIES Legal Matters From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations in the normal course of business. The Company is presently in litigation with Typenex Co-Investment, LLC, a Utah limited liability company (“Typenex”), in the Third Judicial District Court of Salt Lake County, Utah. Typenex is claiming funds due under a convertible promissory note dated June 4, 2015. The Company is actively defending all allegations made by Typenex, and has lodged a counter claim against the plaintiff in the Circuit Court of Hillsborough County, Florida. The Company does not believe the result of this litigation matter will have a material adverse effect on our financial conditions or results of operations. The Company negotiated a settlement with JMJ Financial Inc., a Florida corporation (“JMJ”), and on December 10, 2015, the Company repaid cash of $90,000 as payment in full of the promissory note (See Note 5). Operating Agreements In November 2009, the Company entered into a commercialization agreement whereby the Company agreed to pay royalties of 2% of net revenues. Additionally, the Company agreed to pay 5% of each and every license agreement subscribed for. The contract is cancellable at any time by either party. To date, no amounts are owed under the agreement. Operating Leases On May 1, 2015, the Company moved to new premises. On May 1, 2015, the Company entered into a month to month lease agreement with new landlord with a monthly rental fee of approximately $2,200 AUD and requiring a three month notice, by either party, to terminate agreement. Rent expense for the six months ended December 31, 2015 and 2014 were $9,827 and $5,344 respectively.	NOTE 9 – COMMITMENTS AND CONTINGIENCIES Legal Matters From time to time, the Company may be involved in litigation relating to claims arising out of the Company’s operations in the normal course of business. The Company is presently in litigation with JMJ Financial Inc., a Florida corporation (“JMJ”), in the Circuit Court of Dade County, Florida. JMJ is claiming funds due under a convertible promissory note of Twenty Five thousand Dollars ($25,000.00). The Company is actively defending all allegations made by JMJ, and has lodged a counter claim against the plaintiff. The parties are currently negotiating for a possible settlement, and a mediation is expected to be scheduled in September or October 201 to determine a settlement. The Company does not believe the result of this litigation matter will have a material adverse effect on our financial conditions or results of operations. Operating Agreements In November 2009, the Company entered into a commercialization agreement whereby the Company agreed to pay royalties of 2 5 Operating Leases From July 2013 through April 30, 2015, the Company utilized office space at a certain location. There was no formal lease agreement and no amounts were paid, but the Company had accrued a liability as of April 30, 2015 of approximately $ 21,000 1,000 2,200 Rent expense for the years ended June 30, 2015 and 2014 were $ 3,719 11,016 Settlement and Stipulation Agreement In July 2014, the Company signed a term sheet and a Settlement and Stipulation Agreement (the "Settlement Agreement") with a third party purchaser (the "purchaser") to have that purchaser acquire certain portions of the Company’s liabilities to creditors (“Creditors”) in exchange for an obligation of the Company to issue shares of common stock to the purchaser, which shares of common stock would then be sold by the purchaser and 65 Under the terms of the Settlement Agreement, the variable quantity of common stock will be issued in tranches such that the purchaser would not own more than 9.99 Under the above agreements, in May 2014 the Company also paid an expense fee of $ 25,000 The purchaser entered into agreements through July 2014 with the Creditors to acquire $ 627,998 50,000 75 1,033,000 405,000 During the year ended June 30, 2015, the Company issued a total of 15,587,000 15,587,000 52,907 575,000 310,000 67,000 Equity Purchase Agreement On July 18, 2014 the Company executed an Equity Purchase Agreement (the "agreement") with an investor (the "investor") affiliated with the above purchaser. The Company may sell (put shares) from time to time, during the commitment period discussed below, up to $ 5,000,000 90 9.99 The commitment period is the earlier of the sale of $5,000,000 worth of shares or 24 On July 18, 2014, Company entered into a Registration Rights Agreement with the investor. Pursuant to the terms of the Registration Rights Agreement, the Company is obligated to file a registration statement (the “Registration Statement”) with the SEC to cover the Registrable Securities within one hundred twenty (120) days of closing of an equity purchase. The Company must use its commercially reasonable efforts to cause the Registration Statement relating to the Registered Securities to become effective within five (5) business days after notice from the SEC that such Registration Statement may be declared effective, and keep the Registration Statement effective at all time prior to the termination of the Equity Purchase Agreement until the earliest of (i) date that is three months after the completion of the last Closing date (as defined in the Equity Purchase Agreement), (ii) the date when the investor may sell all Registered Securities under Rule 144 without volume limitations, or (iii) the date the investor no longer owns any of the Registered Securities (collectively, the “Registration Period”). On July 18, 2014 the Company paid a $ 50,000 50,000 10,000,000 50,000 25,000 1,466 0.0025 25,000 51,466

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 8 – RELATED PARTY TRANSACTIONS Since inception, Propanc Health Group Corporation has conducted transactions with directors and director related entities. These transactions included the following: As of December 31, 2015 and June 30, 2015, the Company owed certain directors a total of $ 54,005 79,416 for money loaned to the Company throughout the years. The loan balance owed at December 31, 2015 was not interest bearing (See Note 4). As of December 31, 2015 and June 30 2015, the Company owed two directors a total of $ 33,471 35,108	NOTE 10 – RELATED PARTY TRANSACTIONS Since inception, Propanc Health Group Corporation has conducted transactions with directors and director related entities. These transactions included the following: As of June 30, 2015 and June 30, 2014, the Company owed certain directors a total of $ 79,416 161,975 As of June 30, 2015 and June 30 2014, the Company owed two directors a total of $ 35,108 60,350 On February 4, 2015, the Company entered into a Debt Settlement Agreement with some of these directors whereby the Company issued 33,259,350 17,654,470 41,000 0.0025 127,284 86,455

CONCENTRATIONS AND RISKS

CONCENTRATIONS AND RISKS	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	NOTE 9 – CONCENTRATIONS AND RISKS Concentration of Credit Risk The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through December 31, 2015. Receivable Concentration As of December 31, 2015 and June 30, 2015, the Company’s receivables were 100% related to reimbursements on GST taxes paid. Product and Patent Concentration As of December 31, 2015 the Company was undertaking preclinical activities for their lead product. The Company was also undertaking research to uncover the mechanism of action of their lead product in order to screen new compounds for development. The Company previously expanded by the filing of an international PCT patent application (No. PCT/AU2010/001403) directed to enhanced proenzyme formulations and combination therapies. The international PCT application has been based on previous provisional patent applications capturing the Company’s ongoing research and development in this area. The Company received grant status in South Africa and more recently in Australia and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of our technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, while also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions, include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is granted in South Africa, Australia, and New Zealand. Further provisional patent filings are also expected to be filed to capture and protect additional patentable subject matter that is identified, namely further enhanced formulations, combination treatments, use of recombinant products, modes of action and molecular targets. Foreign Operations As of December 31, 2015 and June 30, 2015, the Company's operations are based in Australia.	NOTE 11 – CONCENTRATIONS AND RISKS Concentration of Credit Risk The Company maintains its cash in banks and financial institutions in Australia. Bank deposits in Australian banks are uninsured. The Company has not experienced any losses in such accounts through June 30, 2015. Receivable Concentration As of June 30, 2015 and 2014, the Company’s receivables were 100 Product and Patent Concentration As of June 30, 2015 the Company was undertaking preclinical activities for their lead product. The Company was also undertaking research to uncover the mechanism of action of their lead product in order to screen new compounds for development. The Company previously expanded by the filing of an international PCT patent application (No. PCT/AU2010/001403) directed to enhanced proenzyme formulations and combination therapies. The international PCT application has been based on previous provisional patent applications capturing the Company’s ongoing research and development in this area. The Company received grant status in South Africa and more recently in Australia and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of our technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, while also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions, include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is granted in South Africa, Australia, and New Zealand. Further provisional patent filings are also expected to be filed to capture and protect additional patentable subject matter that is identified, namely further enhanced formulations, combination treatments, use of recombinant products, modes of action and molecular targets. Foreign Operations As of June 30, 2015 and 2014, the Company's operations are based in Australia.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	NOTE 10 - DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS Derivative Financial Instruments: The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity 3,000,000 2,375,024 60,000 The Company calculates the estimated fair values of the liabilities for derivative instruments using the Black Scholes (“BSM”) option pricing model. The closing price of the Company’s common stock at December 31, 2015 was $ 0.0279 December 31, 2015 Volatility 296 % Expected remaining term 2.75 Risk-free interest rate 1.31 % Expected dividend yield none Convertible Debt Initial Valuations December 31, Volatility 296 % 296 % Expected Remaining Term 1.00 0.26 - 1.19 Risk Free Interest Rate 0.7 % 0.6 % Expected dividend yield none none Fair Value Measurements: The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the BSM option pricing model. Balance at Quoted Prices Significant December in Active Other Significant 31, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 2,511,405 $ — $ — $ 2,511,405 Fair value of liability for warrant derivative instruments $ 82,086 $ — $ — $ 82,086 Total $ 2,593,491 $ — $ — $ 2,593,491 Fair Value of Liability for Derivative Instruments Balance at June 30, 2015 $ 1,049,929 Effects of foreign currency exchange rate changes (14,253) Initial fair value of embedded conversion option derivative liability recorded as debt discount 1,005,925 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 1,369,261 Change in fair value included in statements of operations (817,371) Balance at December 31, 2015 $ 2,593,491	NOTE 12 - DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS Derivative Financial Instruments: The Company applies the provisions of ASC Topic 815-40, Contracts in Entity’s Own Equity 3,000,000 335,000 87,500 The Company calculates the estimated fair values of the liabilities for derivative instruments using the Black Scholes (“BSM”) option pricing model. The closing price of the Company’s common stock at June 30, 2015 was $ 0.0899 Initial Valuation September 30, 2013 June 30, 2014 June 30, 2015 Volatility 53 % 134 % 408 % Expected remaining term 5 4.25 3.25 Risk-free interest rate 0.4 % 0.47 % 1.63 % Expected dividend yield None None None Convertible Debt Initial Valuations June 30, 2015 Volatility 216 - 377 % 408 % Expected remaining term 0.83 – 2.00 0.82 – 1.70 Risk-free interest rate 0.5 – 0.7 % 0.64 % Expected dividend yield None None Fair Value Measurements: The Company measures and reports at fair value the liability for derivative instruments. The fair value liabilities for price adjustable warrants and embedded conversion options have been recorded as determined utilizing the BSM option pricing model. Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 780,281 $ — $ — $ 780,281 Fair value of liability for warrant derivative instruments $ 269,648 $ — $ — $ 269,648 Total $ 1,049,929 $ — $ — $ 1,049,929 Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2014 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Fair value of liability for warrant derivative instruments $ 158,244 $ — $ — $ 158,244 Fair Value of Liability for Derivative Instruments Balance at June 30, 2013 $ - Effects of foreign currency exchange rate changes (2,519) Initial fair value of embedded conversion option derivative liability recorded as debt discount 144,241 Change in fair value included in statements of operations 16,522 Balance at June 30, 2014 158,244 Effects of foreign currency exchange rate changes (42,796) Initial fair value of embedded conversion option derivative liability recorded as debt discount 392,500 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 1,082,567 Change in fair value included in statements of operations (540,586) Balance at June 30, 2015 $ 1,049,929

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 11 – SUBSEQUENT EVENTS Shares issued for conversion of convertible debt On January 4, 2016, pursuant to a conversion notice, $ 20,995 0.0143 1,468,187 On January 4, 2016, pursuant to a conversion notice, $ 54,375 0.02156 2,522,032 On January 6, 2016, pursuant to a conversion notice, $ 40,000 0.02068 1,934,236 On January 6, 2016, pursuant to a conversion notice, $ 21,004 0.014135 1,485,946 On January 8, 2016, pursuant to a conversion notice, $ 40,000 0.02008 1,992,032 On January 8, 2016, pursuant to a conversion notice, $ 10,506 0.0113805 761,050 On January 11, 2016, pursuant to a conversion notice, $ 10,513 0.01375 764,573 On January 12, 2016, pursuant to a conversion notice, $ 10,515 0.012705 827,632 On January 13, 2016, pursuant to a conversion notice, $ 17,650 0.01864 946,889 On January 13, 2016, pursuant to a conversion notice, $ 10,517 0.011825 889,409 On January 13, 2016, pursuant to a conversion notice, $ 20,820 0.01056 1,971,565 On January 14, 2016, pursuant to a conversion notice, $ 82,350 0.0168 4,901,786 On January 19, 2016, pursuant to a conversion notice, $ 10,423 0.009955 1,047,013 On January 20, 2016, pursuant to a conversion notice, $ 5,108 0.009955 513,158 On January 21, 2016, pursuant to a conversion notice, $ 25,000 0.01488 1,680,108 On January 21, 2016, pursuant to a conversion notice, $ 12,513 0.009955 1,256,944 On January 25, 2016, pursuant to a conversion notice, $ 25,000 0.01492 1,675,604 On January 25, 2016, pursuant to a conversion notice, $ 13,567 0.009955 1,362,834 On January 27, 2016, pursuant to a conversion notice, $ 15,661 0.009955 1,573,161 On January 29, 2016, pursuant to a conversion notice, $ 25,000 0.015080 1,657,825 On February 1, 2016, pursuant to a conversion notice, $ 16,722 0.009955 1,679,800 On February 3, 2016, pursuant to a conversion notice, $ 20,000 0.0148 1,351,352 On February 3, 2016, pursuant to a conversion notice, $ 10,456 0.009405 1,111,737 On February 4, 2016, pursuant to a conversion notice, $ 25,000 0.0142 1,760,564 On February 4, 2016, pursuant to a conversion notice, $ 26,145 0.009405 2,779,927 Shares issued for services On December 30, 2015, the Company entered into an agreement, effective on January 1, 2016, with a consultant to provide services over a six month period. The Company agreed to issue the consultant 2,250,000 2,250,000 0.0279 62,775 375,000 On December 31, 2015, the Company entered into an agreement, effective on January 1, 2016, with a law firm to provide legal services. The Company agreed to issue the law firm 1,600,000 1,600,000 0.0279 44,640 1,600,000 On January 4, 2016, the Company issued 1,000,000	NOTE 13 – SUBSEQUENT EVENTS Subsequent to June 30, 2015, the Company received payment of the Secured Investor Note of $ 220,000 20,000 1,997 201,997 0.07 (See Note 6). On July 14, 2015, the Company received payment of three Note Receivables of $ 352,500 17,690 334,810 (See Note 6). On July 15, 2015, the Company paid cash of $ 137,915 104,000 2,872 31,043 On August 14, 2015, pursuant to a conversion notice, $ 20,500 0.02365 866,796 On August 14, 2015, pursuant to a conversion notice, $ 20,802 0.02365 879,585 On August 26, 2015, pursuant to a conversion notice, $ 26,068 0.018425 1,414,843 On August 26, 2015, the Company issued 560,000 0.04 On September 1, 2015, pursuant to a conversion notice, $ 25,723 0.018425 1,396,108 On September 4, 2015, pursuant to a conversion notice, $ 15,648 0.018425 849,263 On September 8, 2015, the Company issued 600,000 0.0369 On September 16, 2015, pursuant to a conversion notice, $ 15,687 0.018975 826,726 On September 18, 2015, pursuant to a conversion notice, $ 15,694 0.017875 877,969 On September 22, 2015, pursuant to a conversion notice, $ 15,638 0.01716 911,294 On September 24, 2015 1,200,000 1,200,000 The debenture has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Note; or (ii) June 24, 2016. th 180,000 0.0346 20

NATURE OF OPERATIONS AND SUMM20

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Policies)	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Accounting Policies [Abstract]
Nature of Operations, Policy [Policy Text Block]	Nature of Operations Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary.	Nature of Operations Propanc PTY LTD was incorporated in Melbourne, Victoria Australia on October 15, 2007, and is based in Richmond, Victoria Australia. Since inception, substantially all of the efforts of the Company have been the development of new cancer treatments targeting high risk patients who need a follow up, nontoxic, long term therapy which prevents the cancer from returning and spreading. The Company anticipates establishing global markets for its technologies. On November 23, 2010, Propanc Health Group Corporation ("the Company", "we", "us", "our") was incorporated in the state of Delaware. In January 2011, to reorganize the Company, Propanc Health Group Corporation acquired all of the outstanding shares of Propanc PTY LTD on a one-for-one basis making it a wholly-owned subsidiary.
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The interim unaudited consolidated financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of the Company’s management, all adjustments (consisting of normal recurring adjustments and reclassifications and non-recurring adjustments) necessary to present fairly our results of operations for the three and six months ended December 31, 2015 and 2014 and cash flows for the six months ended December 31, 2015 and 2014 and our financial position as of December 31, 2015 have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual audited consolidated financial statements have been condensed or omitted from these interim unaudited consolidated financial statements. Accordingly, these interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2015. The June 30, 2015 balance sheet is derived from those statements.
Consolidation, Policy [Policy Text Block]	Principals of Consolidation The unaudited consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation.	Principals of Consolidation The consolidated financial statements include the accounts of Propanc Health Group Corporation and its wholly-owned subsidiary, Propanc PTY LTD. All significant inter-company balances and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statements of operations and other comprehensive income (loss) as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Other Comprehensive Income (Loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation gain 111,879 Ending balance, December 31, 2015 $ 212,847	Foreign Currency Translation and Comprehensive Income (Loss) The Company’s functional currency is the Australian dollar (AUD). For financial reporting purposes, the Australian dollar has been translated into United States dollars ($) and/or USD as the reporting currency. Assets and liabilities are translated at the exchange rate in effect at the balance sheet date. Revenues and expenses are translated at the average rate of exchange prevailing during the reporting period. Equity transactions are translated at each historical transaction date spot rate. Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders’ equity (deficit) as “accumulated other comprehensive income (loss).” Gains and losses resulting from foreign currency transactions are included in the statement of operations and comprehensive loss as other income (expense). There have been no significant fluctuations in the exchange rate for the conversion of Australian dollars to USD after the balance sheet date. Comprehensive income (loss) for all periods presented, includes only foreign currency translation gains (losses). Foreign Currency Items: Beginning balance, June 30, 2013 $ (244,589) Foreign currency translation loss (58,274) Balance, June 30, 2014 (302,863) Foreign currency translation gain 403,831 Ending balance, June 30, 2015 $ 100,968
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments and Fair Value Measurements The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.	Fair Value of Financial Instruments and Fair Value Measurements The Company measures their financial assets and liabilities in accordance with US GAAP. For certain of the Company’s financial instruments, including cash and cash equivalents, accounts and other receivables, accounts payable and accrued expenses and other liabilities, the carrying amounts approximate fair value due to their short maturities. Amounts recorded for loans payable, also approximate fair value because current interest rates available to us for debt with similar terms and maturities are substantially the same. The Company adopted accounting guidance for fair value measurements of financial assets and liabilities. The adoption did not have a material impact on the Company’s results of operations, financial position or liquidity. This standard defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. This guidance does not apply to measurements related to share-based payments. This guidance discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The guidance utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs in which little or no market data exists, therefore developed using estimates and assumptions developed by us, which reflect those that a market participant would use.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of December 31, 2015 or June 30, 2015.	Cash and Cash Equivalents Cash and cash equivalents include cash on hand and at banks, short-term deposits with an original maturity of three months or less with financial institutions, and bank overdrafts. Bank overdrafts are reflected as a current liability on the balance sheets. There were no cash equivalents as of June 30, 2015 or 2014.
Receivables, Policy [Policy Text Block]		Receivables As amounts become uncollectible, they will be charged to an allowance and operations in the period when a determination of uncollectability is made. Any estimates of potentially uncollectible customer accounts receivable will be made based on an analysis of individual customer and historical write-off experience. The Company’s analysis included the age of the receivable account, creditworthiness of the customer and general economic conditions.
Property, Plant and Equipment, Policy [Policy Text Block]		Property, Plant, and Equipment Property and equipment are stated at cost, net of accumulated depreciation. Expenditures for maintenance and repairs are expensed as incurred; additions, renewals, and betterments are capitalized. When property and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation are removed from the respective accounts, and any gain or loss is included in operations. Depreciation of property and equipment is provided using the declining balance method. The depreciable amount is the cost less its residual value. The estimated useful lives are as follows: Machinery and equipment 5
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Patents Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status, or has been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted, or accepted in South Africa, Australia, and New Zealand.	Patents Patent costs are stated at cost and reclassified to intangible assets and amortized on a straight-line basis over the estimated future periods if and once the patent has been granted by a regulatory agency, however, the Company will expense any costs as long as the Company is in the startup stage. Accordingly, as the Company's product was and is not currently approved for market, thus any patent costs incurred from 2013 through 2015 were expensed immediately. Currently, the Company has one International patent pending which was jointly applied for by the Company and another entity. The Company received grant status , or been accepted in South Africa, Australia, and New Zealand. In addition, the United States Patent and Trademark Office or USPTO and European Patent Office or EPO have made preliminary indications that key features of the Company’s technology are patentable. The Company is presently working towards securing a patent in each region, covering as many aspects of its technology as possible, whilst also actively seeking protection throughout Eastern Europe, Asia and South America. Individual countries and regions where the Company is actively seeking patent protection include United States, Canada, Japan, Brazil, China, Mexico, Hong Kong, Singapore, Israel, Chile, Peru, Malaysia, Vietnam, Indonesia, Europe, Russia, India, and South Korea. The patent is now granted , or accepted in South Africa, Australia, and New Zealand.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of Long-Lived Assets In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.	Impairment of Long-Lived Assets In accordance with ASC 360-10, Long-lived assets, which include property and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of long-lived assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.
Compensation Related Costs, Policy [Policy Text Block]		Employee Benefit/Liability Liabilities arising in respect of wages and salaries, annual leave, accumulated sick leave and any other employee benefits expected to be settled within twelve months of the reporting date are measured at their nominal amounts based on remuneration rates which are expected to be paid when the liability is settled. All other employee benefit liabilities are measured at the present value of the estimated future cash outflow to be made in respect of services provided by employees up to the reporting date. All employee liabilities are owed within the next twelve months and therefore, recorded at nominal value.
Goods And Service Tax [Policy Text Block]	Australian Goods and Services Tax (GST) Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of December 31, 2015 and June 30, 2015 the Company was owed $ 6,808	Australian Goods and Services Tax (GST) Revenues, expenses and balance sheet items are recognized net of the amount of GST except payable and receivable balances which are shown inclusive of GST. The GST incurred is payable on revenues to, and recoverable on purchases from, the Australian Taxation Office. Cash flows are presented in the statements of cash flow on a gross basis, except for the GST component of investing and financing activities, which are disclosed as operating cash flows. As of June 30, 2015 and June 30, 2014 the Company was owed $ 11,647 946
Derivatives, Policy [Policy Text Block]	Derivative Instruments ASC Topic 815, Derivatives and Hedging	Derivative Instruments ASC Topic 815, Derivatives and Hedging
Convertible Notes [Policy Text Block]	Convertible Notes With Variable Conversion Options The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion.	Convertible Notes With Variable Conversion Options The Company has entered into convertible notes, some of which contain variable conversion options, whereby the outstanding principal and accrued interest may be converted, by the holder, into common shares at a fixed discount to the price of the common stock at the time of conversion. The Company treats these convertible notes as stock settled debt under ASC 480 and measures the fair value of the notes at the time of issuance, which is the result of the share price discount at the time of conversion, and records the put premium as accretion to interest expense to the date of first conversion.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods.	Income Taxes The Company is governed by Australia and United States income tax laws, which are administered by the Australian Taxation Office and the United States Internal Revenue Service, respectively. The Company follows FASB ASC 740 when accounting for income taxes, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statements and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The Company adopted provisions of ASC 740, Sections 25 through 60, “Accounting for Uncertainty in Income Taxes." These sections provide detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in the financial statements. Tax positions must meet a “more-likely-than-not” recognition threshold at the effective date to be recognized upon the adoption of ASC 740 and in subsequent periods. Upon the adoption of ASC 740, the Company had no unrecognized tax benefits. During the years ended June 30, 2015 and 2014 no adjustments were recognized for uncertain tax benefits. The years 2008 through 2015 are subject to examination by the Australian Taxation Office. The years ended June 30, 2012 through 2015 is subject to examination by the United States Internal Revenue Service.
Research and Development Expense, Policy [Policy Text Block]	Research and Development Costs and Tax Credits In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the six months ended December 31, 2015 and 2014 were $ 296,277 6,322 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt.	Research and Development Costs and Tax Credits In accordance with ASC 730-10, research and development costs are expensed when incurred. Total research and development costs for the years ended June 30, 2015 and 2014 were $ 134,319 8,168 The Company may apply for research and development tax concessions with the Australian Taxation Office on an annual basis. Although the amount is possible to estimate at year end, the Australian Taxation Office may reject or materially alter the claim amount. Accordingly, the Company does not recognize the benefit of the claim amount until cash receipt since collectability is not certain until such time. The tax concession is a refundable credit. If the Company has net income then the Company can receive the credit which reduces its income tax liability. If the Company has net losses then the Company may still receive a cash payment for the credit, however, the Company's net operating loss carryforwards are reduced by the gross equivalent loss that would produce the credit amount when the income tax rate is applied to that gross amount. The concession is recognized as an income tax benefit, in operations, upon receipt. During the years ended June 30, 2015 and 2014, the Company applied for and received from the Australian Taxation Office a research and development tax credit in the amount of $ 77,470 48,267
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock Based Compensation The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”.	Stock Based Compensation The Company records stock based compensation in accordance with ASC section 718, “Stock Compensation” and Staff Accounting Bulletin (SAB) No. 107 (SAB 107) issued by the SEC in March 2005 regarding its interpretation of ASC 718. ASC 718 requires the fair value of all stock-based employee compensation awarded to employees to be recorded as an expense over the related requisite service period. The Company values any employee or non-employee stock based compensation at fair value using the Black-Scholes Option Pricing Model. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 505-50 “Equity-Based Payments to Non-Employees”.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition	Revenue Recognition In accordance with SEC Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition,
Start-up Activities, Cost Policy [Policy Text Block]		Start-up Costs In accordance with ASC 720-15-15, start-up costs are expensed as incurred.
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Net Loss Per Common Share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the six months ended December 31 2015, there were 33,569,634 409,272,805	Basic and Diluted Net Loss Per Common Share Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding for the period and, if dilutive, potential common shares outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon exercise of common stock equivalents such as stock options, warrants and convertible debt instruments. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. As a result, the basic and diluted per share amounts for all periods presented are identical. For the years ended June 30 2015 and 2014, there were 7,379,158 3,000,000 335,716,597 6,069,667
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after December 31, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company is evaluating or has implemented the following at December 31, 2015: In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2016. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs,"	Recently Adopted Accounting Pronouncements Financial Accounting Standards Board, Accounting Standard Updates which are not effective until after June 30, 2015 are not expected to have a significant effect on the Company’s consolidated financial position or results of operations. The Company implemented the following at June 30, 2015: In June 2014, the FASB issued ASU No. 2014-10, which amended Accounting Standards Codification (ASC) Topic 915 Development Stage Entities. The amendment eliminates certain financial reporting requirements surrounding development stage entities, including an amendment to the variable interest entities guidance in ASC Topic 810, Consolidation. The amendment removes the definition of a development stage entity from the ASC, thereby removing the financial reporting distinction between development stage entities and other entities from U.S. GAAP. Consequently, the amendment eliminates the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. This amendment is effective for fiscal years beginning after December 15, 2014, and interim periods therein. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company has made the election to early adopt this amendment effective June 30, 2014 and, as a result, the Company is no longer presenting or disclosing the information previously required under Topic 915. The early adoption was made to reduce data maintenance by removing all incremental financial reporting requirements for development stage entities. The adoption of this amendment alters the disclosure requirements of the Company, but it does not have any material impact on the Company's financial position or results of operations for the current or any prior reporting periods. In August 2014, the FASB issued ASU 2014-15, “Presentation of Financial Statements – Going Concern (Topic 205-40)”, which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period. If substantial doubt exists, additional disclosure is required. This new standard will be effective for the Company for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company expects to adopt this new standard as of December 31, 2015. The Company does not expect this ASU to have a material impact on its consolidated financial statements. On May 8, 2015, the FASB issued ASU 2015-08, “Business Combinations (Topic 805) Pushdown Accounting In April 2015, the Financial Accounting Standards Board issued Accounting Standards Update No. 2015-03, "Simplifying the Presentation of Debt Issuance Costs,"

NATURE OF OPERATIONS AND SUMM21

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Tables)	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Accounting Policies [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	Changes in Accumulated Other Comprehensive Income (Loss) by Component during the six months ended December 31, 2015 was as follows: Foreign Beginning balance, June 30, 2015 $ 100,968 Foreign currency translation gain 111,879 Ending balance, December 31, 2015 $ 212,847	Changes in Accumulated Other Comprehensive Income (Loss) by component during the years ended June 30, 2015 and 2014 were as follows: Foreign Currency Items: Beginning balance, June 30, 2013 $ (244,589) Foreign currency translation loss (58,274) Balance, June 30, 2014 (302,863) Foreign currency translation gain 403,831 Ending balance, June 30, 2015 $ 100,968

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Jun. 30, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property, plant, and equipment consist of the following as of June 30, 2015 2014 Office equipment at cost $ 15,732 $ 14,968 Less: Accumulated depreciation (12,238) (14,968) Total property, plant, and equipment $ 3,494 $ -

CONVERTIBLE NOTES (Tables)

CONVERTIBLE NOTES (Tables)	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Debt Disclosure [Abstract]
Schedule of convertible debenture [Table Text Block]	Convertible notes at December 31, 2015 were as follows: Convertible notes and debenture $ 3,630,024 Unamortized discounts (2,341,232) Accrued interest 82,802 Premium 577,925 Convertible notes, net $ 1,949,519	Convertible notes at June 30, 2015 and 2014 were as follows: June 30, 2015 June 30, 2014 Convertible notes and debenture $ 1,455,000 $ 366,296 Unamortized discounts (415,467) (121,059) Accrued interest 26,989 - Premium, net 727,853 27,187 Convertible notes, net $ 1,794,375 $ 272,424

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	The components for the provision for income taxes are as follows: Year Ended June 30, June 30, 2015 2014 Current Taxes $ (77,470) $ (48,267) Deferred Taxes - - Income Taxes Expense (Benefit) $ (77,470) $ (48,267)
Schedule Of Differences Between Income Taxes And Provision For Income Taxes [Table Text Block]	The items accounting for the difference between income taxes at the Australia statutory rate and the provision for income taxes are as follows: Year Ended June 30, June 30, 2015 2014 Impact on Impact on Amount Rate Amount Rate Income Tax Expense (Benefit) at Australia Statutory Rate $ (672,087) (19.26) % $ (274,229) (31.24) % Expenses Paid by Parent on Behalf of Foreign Subsidiary 156,410 4.48 % 92,480 10.54 % R&D Refundable Tax Credit (77,470) (2.22) % (48,267) (5.50) % Reduction of NOL Carryforward Due to R&D Tax Credit 77,470 2.22 % 48,267 5.50 % Change in Deferred Tax Valuation Allowance (355,636) (10.19) % 260,533 29.68 % Foreign Exchange Rate Changes 793,843 22.74 % (127,051) (14.47) % Total Income Tax Expense (Benefit) $ (77,470) (2.22) % $ (48,267) (5.50) %
Schedule Of Deferred Income Taxes [Table Text Block]	Significant components of the Company's net deferred income taxes are as follows: June 30, June 30, 2015 2014 Current Deferred Tax Assets Warrant Derivative Liability $ 88,204 $ 28,209 Provision for Annual Leave 21,426 18,848 Superannuation - 3,815 Total Current Deferred Tax Assets $ 109,630 $ 50,872 Current Deferred Tax Liabilities Prepaid Investor Services $ - $ - Prepaid Expenses - - Prepaid Insurance - - Accounts Payable/Trade Creditors - - Patent Costs - - Total Current Deferred Tax Liabilities $ - $ - Non-Current Deferred Tax Assets Prepaid Investor Services $ 185,025 $ 751,917 Capital Raising Costs 23,261 28,622 Legal Costs 23,583 29,019 Intellectual Property 11,612 14,288 Patent Costs 59,995 59,473 Formation Expense 7,117 8,757 Net Operating Loss Carryover 3,426,149 3,259,060 Foreign Exchange Loss (OCI) (30,290) 90,859 Total Non-Current Deferred Tax Assets 3,706,452 4,241,995 Deferred Tax Valuation Allowance (3,816,082) (4,292,867) Total Non-Current Deferred Tax Assets (109,630) (50,872) Total Deferred Tax Assets (Net) $ - $ -

STOCKHOLDERS' DEFICIT (Tables)

STOCKHOLDERS' DEFICIT (Tables)	12 Months Ended
	Jun. 30, 2015
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following table summarizes warrant activity for the years ended June 30, 2015 and 2014: Weighted Number of Average Shares Price Per Share Outstanding at June 30, 2013 - $ - Issued 3,000,000 0.07 Exercised - - Expired - - Outstanding at June 30, 2014 3,000,000 0.07 Issued 4,379,158 0.04 Exercised - - Expired - - Outstanding at June 30, 2015 7,379,158 $ 0.05 Exercisable at June 30, 2015 7,379,158 $ 0.05 Outstanding and Exercisable: Weighted average remaining contractual term 4.21 Aggregate intrinsic value $ 319,774

DERIVATIVE FINANCIAL INSTRUME26

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Tables)	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]	Warrants December 31, 2015 Volatility 296 % Expected remaining term 2.75 Risk-free interest rate 1.31 % Expected dividend yield none Convertible Debt Initial Valuations December 31, Volatility 296 % 296 % Expected Remaining Term 1.00 0.26 - 1.19 Risk Free Interest Rate 0.7 % 0.6 % Expected dividend yield none none	Warrants Initial Valuation September 30, 2013 June 30, 2014 June 30, 2015 Volatility 53 % 134 % 408 % Expected remaining term 5 4.25 3.25 Risk-free interest rate 0.4 % 0.47 % 1.63 % Expected dividend yield None None None Convertible Debt Initial Valuations June 30, 2015 Volatility 216 - 377 % 408 % Expected remaining term 0.83 – 2.00 0.82 – 1.70 Risk-free interest rate 0.5 – 0.7 % 0.64 % Expected dividend yield None None
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2015: Balance at Quoted Prices Significant December in Active Other Significant 31, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 2,511,405 $ — $ — $ 2,511,405 Fair value of liability for warrant derivative instruments $ 82,086 $ — $ — $ 82,086 Total $ 2,593,491 $ — $ — $ 2,593,491	The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2015 and 2014: Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2015 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Embedded conversion option liabilities $ 780,281 $ — $ — $ 780,281 Fair value of liability for warrant derivative instruments $ 269,648 $ — $ — $ 269,648 Total $ 1,049,929 $ — $ — $ 1,049,929 The following tables summarize the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2014: Balance at Quoted Prices Significant June in Active Other Significant 30, Markets for Observable Unobservable 2014 Identical Assets Inputs Inputs (Level 1) (Level 2) (Level 3) Fair value of liability for warrant derivative instruments $ 158,244 $ — $ — $ 158,244
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	The following is a roll forward for the six months ended December 31, 2015 of the fair value liability of price adjustable derivative instruments: Fair Value of Liability for Derivative Instruments Balance at June 30, 2015 $ 1,049,929 Effects of foreign currency exchange rate changes (14,253) Initial fair value of embedded conversion option derivative liability recorded as debt discount 1,005,925 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 1,369,261 Change in fair value included in statements of operations (817,371) Balance at December 31, 2015 $ 2,593,491	The following is a roll forward for the years ended June 30, 2015 and 2014 of the fair value liability of price adjustable derivative instruments: Fair Value of Liability for Derivative Instruments Balance at June 30, 2013 $ - Effects of foreign currency exchange rate changes (2,519) Initial fair value of embedded conversion option derivative liability recorded as debt discount 144,241 Change in fair value included in statements of operations 16,522 Balance at June 30, 2014 158,244 Effects of foreign currency exchange rate changes (42,796) Initial fair value of embedded conversion option derivative liability recorded as debt discount 392,500 Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO 1,082,567 Change in fair value included in statements of operations (540,586) Balance at June 30, 2015 $ 1,049,929

NATURE OF OPERATIONS AND SUMM27

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance			$ 100,968	$ (302,863)	$ (302,863)	$ (244,589)
Foreign currency translation gain / loss	$ (146,551)	$ 103,320	111,879	$ 218,137	403,831	(58,274)
Ending balance	$ 212,847		$ 212,847		$ 100,968	$ (302,863)

NATURE OF OPERATIONS AND SUMM28

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING POLICIES (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
GST tax receivable	$ 6,808		$ 6,808		$ 11,647	$ 946
Income Tax Expense (Benefit)	72,000	$ 82,440	72,000	$ 82,440	77,470	48,267
Research and development	$ 142,803	$ 2,443	$ 296,277	$ 6,322	$ 134,319	$ 8,168
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			409,272,805		335,716,597	6,069,667
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount			33,569,634		7,379,158	3,000,000
Machinery and Equipment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Property, Plant and Equipment, Useful Life					5 years

GOING CONCERN (Details Textual)

GOING CONCERN (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Going Concern [Line Items]
Net loss	$ (3,562,067)	$ (345,479)	$ (4,400,961)	$ (1,128,779)	$ (3,412,754)	$ (829,564)
Net Cash Used In Operating Activities			1,488,222	$ 271,996	1,426,479	226,442
Stockholders Equity	(3,355,864)		(3,355,864)		(3,053,516)	(1,408,314)	$ (792,476)
Working Capital Deficit	3,361,141		3,361,141		3,058,694
Retained Earnings (Accumulated Deficit)	$ (25,366,632)		$ (25,366,632)		$ (20,965,671)	$ (17,552,917)

DUE TO DIRECTORS - RELATED PA30

DUE TO DIRECTORS - RELATED PARTIES (Details Textual) - USD ($)	Feb. 04, 2015	Jul. 02, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2015	Jan. 30, 2015
Related Party Transaction [Line Items]
Due to Related Parties, Current			$ 35,108	$ 60,350	$ 33,471
Decrease In Liability Due To Director			44,000
Increase In The Liability Part Of Settlement Agreement						$ 44,000
Debt Conversion, Converted Instrument, Amount		$ 139,680	$ 152,285	$ 0
Director [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 14,000

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014
Property, Plant and Equipment [Line Items]
Office equipment at cost		$ 15,732	$ 14,968
Less: Accumulated depreciation		(12,238)	(14,968)
Total property, plant, and equipment	$ 3,671	$ 3,494	$ 0

PROPERTY AND EQUIPMENT (Detai32

PROPERTY AND EQUIPMENT (Details Textual) - USD ($)	6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 340	$ 0	$ 81	$ 538

LOANS AND NOTES PAYABLE (Detail

LOANS AND NOTES PAYABLE (Details Textual)	Feb. 04, 2015USD ($)$ / sharesshares	Jul. 02, 2014USD ($)$ / sharesshares	Jan. 30, 2015USD ($)shares	Nov. 04, 2014shares	Sep. 11, 2014USD ($)shares	Jul. 18, 2014USD ($)	May. 31, 2014USD ($)	Sep. 30, 2013USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2015USD ($)	Dec. 31, 2015AUD	Dec. 31, 2014USD ($)	Jun. 30, 2015USD ($)$ / shares	Jun. 30, 2014USD ($)	Jun. 30, 2013USD ($)	Aug. 06, 2014USD ($)	Jul. 31, 2014USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Conversion, Converted Instrument, Amount		$ 139,680												$ 152,285	$ 0
Decrease In Liability Due To Director														44,000
Notes Payable, Current									$ 2,189		$ 2,189			27,558	33,909
Debt Instrument, Face Amount																	$ 250,000
Debt Conversion, Converted Instrument, Shares Issued | shares		2,183,333
Debt Conversion, Original Debt, Amount						$ 50,000
Debt Instrument, Convertible, Conversion Price | $ / shares		$ 0.0709
Increase In The Liability Part Of Settlement Agreement			$ 44,000
Conversion of Stock, Amount Converted											636,348		$ 37,032	71,370	0
Other Liabilities			575,000
Gains (Losses) on Extinguishment of Debt, Total									(58,893)	$ 71,147	(58,893)		34,884	375,547	0
Interest Payable									7,339		7,339
Other Long-term Debt, Current														27,558	33,909
Payments for Loans											21,500		20,000	28,455	45,512
Repayments of Related Party Debt											21,500	AUD 29,744
Repayments of Other Debt											23,852	AUD 33,000	0
Foreign Currency Transaction Gain (Loss), Unrealized											20,509		$ 0	$ (31,548)	0
Loans from Directors [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 27,000
Debt Conversion, Converted Instrument, Shares Issued | shares	33,259,350
Settlement And Lock Up Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Other Liabilities			575,000
Settlement And Lock Up Agreement [Member] | Loans from Directors [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Increase In The Liability Part Of Settlement Agreement			109,000
Settlement Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities | shares				8,161,000	7,426,000
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments					$ 81,396
Promissory Note [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Conversion, Converted Instrument, Amount			50,000
Debt Conversion, Original Debt, Amount							$ 25,000
Debt Instrument, Convertible, Conversion Price | $ / shares														$ 0.0025
Gain Or Loss On Debt Conversion Original Debt														$ 51,466
Conversion of Stock, Amount Converted			25,000											25,000
Gains (Losses) on Extinguishment of Debt, Total			51,466
Interest Payable			$ 1,466
Promissory Note [Member] | Settlement And Lock Up Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Conversion, Converted Instrument, Shares Issued | shares			10,000,000
Debt Conversion, Original Debt, Amount			$ 50,000
Promissory Note [Member] | Settlement Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest Payable							$ 1,466
Lender [Member] | Settlement Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Instrument, Unamortized Premium			17,000
Debt Instrument, Face Amount			50,000
Gains (Losses) on Extinguishment of Debt, Total			$ 310,000
Non-Interest Bearing [Member] | Investor [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Instrument, Fee Amount						50,000
Non-Interest Bearing [Member] | Promissory Note [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Instrument, Fee Amount						$ 50,000
Two unrelated parties [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term Debt, Gross																$ 33,614
Debt Instrument, Interest Rate During Period																10.00%
Debt Conversion, Converted Instrument, Amount								$ 27,963
unrelated parties [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term Debt, Gross															$ 9,419
Debt Instrument, Interest Rate During Period															10.00%
Notes Payable, Current														27,558
unrelated parties [Member] | Settlement Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes Payable, Current															$ 33,909
unrelated parties [Member] | Lender [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Instrument, Fee Amount																		$ 50,000
Notes Payable, Current																		1,033,000
Debt Instrument, Unamortized Premium																		355,000
Debt Instrument, Face Amount																		$ 628,000
unrelated parties [Member] | Non-Interest Bearing [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term Debt, Gross															18,839
Directors and Officer [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Long-term Debt, Gross									$ 54,005		$ 54,005			79,416	$ 161,975
Director [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 14,000
Debt Conversion, Converted Instrument, Shares Issued | shares	17,654,470
Director [Member] | Loans from Directors [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 41,000
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 0.0025
Gain Or Loss On Debt Conversion Original Debt	$ 86,455
Conversion of Stock, Amount Converted	127,284
Gains (Losses) on Extinguishment of Debt, Total	$ 86,455
Director [Member] | Settlement Agreement [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Decrease In Liability Due To Director														$ 127,000

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Current Taxes					$ (77,470)	$ (48,267)
Deferred Taxes					0	0
Income Taxes Expense (Benefit)	$ (72,000)	$ (82,440)	$ (72,000)	$ (82,440)	$ (77,470)	$ (48,267)

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Income Tax Expense (Benefit) at Australia Statutory Rate					$ (672,087)	$ (274,229)
Expenses Paid by Parent on Behalf of Foreign Subsidiary					156,410	92,480
R&D Refundable Tax Credit					(77,470)	(48,267)
Reduction of NOL Carryforward Due to R&D Tax Credit					77,470	48,267
Change in Deferred Tax Valuation Allowance					(355,636)	260,533
Foreign Exchange Rate Changes					793,843	(127,051)
Total Income Tax Expense (Benefit)	$ (72,000)	$ (82,440)	$ (72,000)	$ (82,440)	$ (77,470)	$ (48,267)
Income Tax Expense (Benefit) at Australia Statutory Rate, Impact on Rate					(19.26%)	(31.24%)
Expenses paid by parent on behalf of foreign subsidiary, Impact on Rate					4.48%	10.54%
R&D Refundable Tax Credit, Impact on Rate, Impact on Rate					(2.22%)	(5.50%)
Reduction of NOL Carryforward Due to R&D Tax Credit, Impact on Rate					2.22%	5.50%
Change in deferred Tax Valuation Allowance, Impact on Rate					(10.19%)	29.68%
Foreign Exchange Rate Changes, Impact on Rate					22.74%	(14.47%)
Total Income Tax Expense (Benefit), Impact on Rate					(2.22%)	(5.50%)

INCOME TAXES (Details 2)

INCOME TAXES (Details 2) - USD ($)	Jun. 30, 2015	Jun. 30, 2014
Current Deferred Tax Assets
Total Current Deferred Tax Assets	$ 109,630	$ 50,872
Current Deferred Tax Liabilities
Total Current Deferred Tax Liabilities	0	0
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	3,706,452	4,241,995
Deferred Tax Valuation Allowance	(3,816,082)	(4,292,867)
Total Non-Current Deferred Tax Assets	(109,630)	(50,872)
Total Deferred Tax Assets (Net)	0	0
Warrant Derivative Liability [Member]
Current Deferred Tax Assets
Total Current Deferred Tax Assets	88,204	28,209
Provision For Annual Leave [Member]
Current Deferred Tax Assets
Total Current Deferred Tax Assets	21,426	18,848
Superannuation [Member]
Current Deferred Tax Assets
Total Current Deferred Tax Assets	0	3,815
Prepaid Investor Services [Member]
Current Deferred Tax Liabilities
Total Current Deferred Tax Liabilities	0	0
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	185,025	751,917
Prepaid Expenses [Member]
Current Deferred Tax Liabilities
Total Current Deferred Tax Liabilities	0	0
Prepaid Insurance [Member]
Current Deferred Tax Liabilities
Total Current Deferred Tax Liabilities	0	0
Accounts Payable/Trade Creditors [Member]
Current Deferred Tax Liabilities
Total Current Deferred Tax Liabilities	0	0
Patent Costs [Member]
Current Deferred Tax Liabilities
Total Current Deferred Tax Liabilities	0	0
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	59,995	59,473
Capital Raising Costs [Member]
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	23,261	28,622
Legal Costs [Member]
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	23,583	29,019
Intellectual Property [Member]
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	11,612	14,288
Formation Expense [Member]
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	7,117	8,757
Net Operating Loss Carryover [Member]
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	3,426,149	3,259,060
Foreign Exchange Loss (OCI) [Member]
Non-Current Deferred Tax Assets
Total Non-Current Deferred Tax Assets	$ (30,290)	$ 90,859

INCOME TAXES (Details Textual)

INCOME TAXES (Details Textual) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Operating Income (Loss)	$ (1,143,821)	$ (249,441)	$ (2,151,212)	$ (487,579)	$ (1,705,587)	$ (761,221)
Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount					1,527,228
Australian Taxation Office [Member]
Operating Income (Loss)					$ 12,486,000

CONVERTIBLE NOTES (Details)

CONVERTIBLE NOTES (Details) - USD ($)	Dec. 31, 2015	Jun. 30, 2015	Jun. 04, 2015	Aug. 06, 2014	Jun. 30, 2014
Debt Instrument [Line Items]
Unamortized discounts			$ (20,000)	$ (25,000)
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Convertible notes and debenture	$ 3,630,024	$ 1,455,000			$ 366,296
Unamortized discounts	(2,341,232)	(415,467)			(121,059)
Accrued interest	82,802	26,989			0
Premium	577,925	727,853			27,187
Convertible notes, net	$ 1,949,519	$ 1,794,375			$ 272,424

CONVERTIBLE NOTES (Details Text

CONVERTIBLE NOTES (Details Textual)	Dec. 10, 2015USD ($)	Jul. 15, 2015USD ($)	Feb. 17, 2015	Dec. 10, 2014USD ($)	Jul. 02, 2014USD ($)$ / sharesshares	Oct. 31, 2015shares	May. 19, 2015	Apr. 27, 2015USD ($)	Apr. 24, 2015USD ($)	Apr. 20, 2015USD ($)	Mar. 20, 2015	Mar. 12, 2015USD ($)$ / shares	Feb. 20, 2015USD ($)	Feb. 15, 2015USD ($)	Feb. 10, 2015	Jan. 30, 2015USD ($)	Nov. 17, 2014USD ($)	Aug. 06, 2014USD ($)$ / shares	May. 30, 2014USD ($)	May. 29, 2014USD ($)	Sep. 30, 2013USD ($)$ / sharesshares	Sep. 30, 2013USD ($)$ / shares	Dec. 31, 2015USD ($)$ / shares	Dec. 31, 2014USD ($)	Jun. 30, 2015USD ($)$ / shares	Jun. 30, 2014USD ($)	Jun. 30, 2013USD ($)	Jun. 04, 2015USD ($)	Jul. 02, 2014AUD / shares	May. 08, 2014USD ($)	Sep. 30, 2013AUDAUD / shares
Debt Instrument [Line Items]
Debt Instrument, Face Amount																		$ 250,000
Debt Instrument, Convertible, Conversion Price | $ / shares					$ 0.0709
Share Price | $ / shares																							$ 0.0279		$ 0.0899
Debt Instrument, Unamortized Discount																		25,000										$ 20,000
DerivativeLiabilities																							$ 2,593,491		$ 1,049,929	$ 158,244	$ 0
Stock Issued During Period, Shares, New Issues | shares						1,500,000
Discounts related to warrants issued with convertible debenture																							1,619,075	$ 0	0	$ 133,095
Debt Instrument, Periodic Payment					$ 154,798
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger							55.00%
Interest Payable																							7,339
Six Month Consulting Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage														5.00%
Debt Instrument, Maturity Date														Aug. 15, 2015
Debt Instrument, Increase, Accrued Interest														$ 1,677									2,764
Debt Instrument, Unamortized Premium														$ 60,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger														60.00%
Debt Instrument, Periodic Payment, Principal																							85,000
Additionally Debt Instrument Unamortized Premium																							56,667
Two Year Consulting Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage												10.00%
Debt Instrument, Maturity Date												Mar. 11, 2017
Debt Instrument, Convertible, Conversion Price | $ / shares												$ 0.0175
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger												75.00%
Interest Payable																							$ 4,849		$ 1,825
August 2013 Notes [Member]
Debt Instrument [Line Items]
Notes Payable																					$ 63,196	$ 63,196
September 2013 Notes [Member]
Debt Instrument [Line Items]
Notes Payable																					46,446	$ 46,446
Warrant [Member]
Debt Instrument [Line Items]
Fair Value Assumptions, Expected Volatility Rate																						53.00%	296.00%		408.00%	134.00%
Fair Value Assumptions, Expected Term																						5 years	2 years 9 months		3 years 3 months	4 years 3 months
Fair Value Assumptions, Risk Free Interest Rate																						0.40%	1.31%		1.63%	0.47%
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																$ 25,000		250,000			$ 139,680	$ 139,680								$ 25,000	AUD 150,000
Debt Instrument, Interest Rate, Stated Percentage																					12.00%	12.00%								10.00%	12.00%
Debt Instrument, Convertible, If-converted Value in Excess of Principal																											$ 27,963
Debt Instrument, Increase, Accrued Interest					$ 15,118											$ 1,466									$ 2,134
Debt Instrument, Convertible, Conversion Price | (per share)					$ 0.0709																								AUD 0.075		AUD 0.075
Debt Instrument, Unamortized Discount																		$ 25,000
Stock Issued During Period, Shares, New Issues | shares					2,183,333
Debt Instrument, Debt Default, Interest Rate																			16.00%
Discounts related to warrants issued with convertible debenture					$ 139,680
Percentage of Consideration Received																		10.00%
Interest Rate on Payment of Consideration																		0.00%
Debt Instrument, Interest Rate During Period																		12.00%
Debt Instrument, Periodic Payment																									$ 25,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																		60.00%							12.00%
Debt Instrument, Convertible, Stock Price Trigger | $ / shares																		$ 0.09
Interest Payable																									$ 250,000
Convertible Notes Payable [Member] | Warrant [Member]
Debt Instrument [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities | shares																					3,000,000
Debt Instrument, Convertible, Conversion Price | (per share)																					$ 0.0698	$ 0.0698									AUD 0.075
Share Price | $ / shares																					$ 0.20	$ 0.20
Fair Value Assumptions, Expected Volatility Rate																					53.00%
Fair Value Assumptions, Expected Term																					27 months
Fair Value Assumptions, Risk Free Interest Rate																					0.40%
Debt Instrument, Unamortized Discount																					$ 400,000	$ 400,000
DerivativeLiabilities																					140,000	$ 140,000
Increase Decrease In Derivative Liabilities																					$ 260,000
Convertible Notes Payable One [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																				$ 75,000					60,453
Debt Instrument, Interest Rate, Stated Percentage																				8.00%
Debt Instrument, Maturity Date																				May 29, 2015
Debt Instrument, Unamortized Discount																				$ 61,364
Debt Instrument, Convertible, Threshold Trading Days																				180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																				55.00%
Interest and Debt Expense																									51,089	$ 10,275
Debt Instrument, Periodic Payment, Principal	$ 27,500																								14,547
Debt Instrument, Periodic Payment, Interest	3,607																								218
Additionally Debt Instrument Unamortized Premium	90,000																								61,364
Prepayment Penalties	$ 58,893
Convertible Notes Payable One [Member] | Third Party [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest																									4,352
Convertible Notes Payable Two [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																				$ 75,000					63,245
Debt Instrument, Interest Rate, Stated Percentage																				8.00%
Debt Instrument, Maturity Date																				May 29, 2015
Debt Instrument, Unamortized Discount																				$ 61,364
Debt Instrument, Convertible, Terms of Conversion Feature															The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Companys common stock for the ten prior trading days prior to the date upon which the conversion notice was received.
Debt Instrument, Convertible, Threshold Trading Days																				180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																				55.00%
Interest and Debt Expense																							$ 9,409		51,089	10,275
Debt Instrument, Periodic Payment, Principal																							45,000		11,755
Debt Instrument, Periodic Payment, Interest																							1,887		553
Additionally Debt Instrument Unamortized Premium																							36,818		61,364
Convertible Notes Payable Two [Member] | Third Party [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest																									3,313
Convertible Notes Payable Three [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																			$ 50,000
Debt Instrument, Interest Rate, Stated Percentage																			8.00%
Debt Instrument, Maturity Date																			May 30, 2015
Debt Instrument, Unamortized Discount																			$ 40,909
Debt Instrument, Convertible, Terms of Conversion Feature			The note is convertible at the option of the holder at any time after 180 days at a rate of 55% of the lowest trading bid price of the Companys common stock for the ten prior trading days prior to the date upon which the conversion notice was received.
Debt Instrument, Convertible, Threshold Trading Days																			180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																			55.00%
Interest and Debt Expense																							9,409		34,273	$ 6,636
Debt Instrument, Periodic Payment, Principal																							45,000		50,000
Debt Instrument, Periodic Payment, Interest																							2,229		3,346
Additionally Debt Instrument Unamortized Premium																							36,818		40,909
Convertible Notes Payable Four [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																	$ 43,000
Debt Instrument, Interest Rate, Stated Percentage																	8.00%
Debt Instrument, Maturity Date																	Aug. 20, 2015
Debt Instrument, Unamortized Discount																	$ 31,138
Debt Instrument, Convertible, Terms of Conversion Feature												The note is convertible at the option of the holder at any time at a rate of 55% of the Companys common stock for the average of the lowest three trading prices in the ten prior trading days including the date upon which the conversion notice was received.
Debt Instrument, Convertible, Threshold Trading Days																	180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																	58.00%
Debt Instrument, Periodic Payment, Principal																							170,500		27,851
Debt Instrument, Periodic Payment, Interest																							8,580		1,527
Additionally Debt Instrument Unamortized Premium																							139,500
Repayments of Debt																									61,632
Debt Instrument, Annual Principal Payment																									43,000
Prepayment Penalties																									17,105
Debt Instrument, Increase (Decrease), Other, Net																									3,287
Convertible Notes Payable Five [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 28,000
Debt Instrument, Interest Rate, Stated Percentage				8.00%
Debt Instrument, Maturity Date				Sep. 12, 2015
Debt Instrument, Increase, Accrued Interest																									853
Debt Instrument, Unamortized Discount				$ 20,276
Debt Instrument, Convertible, Terms of Conversion Feature											The note is convertible at the option of the holder at any time at a rate of 55% of the lowest trading bid price of the Companys common stock for the average of the lowest three trading priced in the ten prior trading days including the date upon which the conversion notice was received.
Debt Instrument, Convertible, Threshold Trading Days				180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger				58.00%
Debt Instrument, Periodic Payment, Principal																							150,000		15,657
Debt Instrument, Periodic Payment, Interest																							9,436
Additionally Debt Instrument Unamortized Premium																							122,727
Repayments of Debt																									38,654
Debt Instrument, Annual Principal Payment																									28,000
Prepayment Penalties																									9,801
Debt Instrument, Increase (Decrease), Other, Net																									4,619
Convertible Back-End Notes Payable One [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																			$ 75,000
Debt Instrument, Percentage of Repayment, If prepaid within 60 days of the issuance date																			130.00%
Debt Instrument, Percentage of Repayment, if prepaid 60 but less than 121 days after the issuance date																			140.00%
Debt Instrument, Percentage of Repayment, if prepaid 120 but less than 180 days after the issuance date																			150.00%
Convertible Back-End Notes Payable Two [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																			$ 75,000
Convertible Back-End Notes Payable Three [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																			$ 50,000
Convertible Back-End Notes Payable [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger											55.00%
Convertible Note Payable Eight [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount												$ 104,000
Debt Instrument, Interest Rate, Stated Percentage												8.00%
Debt Instrument, Maturity Date												Dec. 16, 2015
Debt Instrument, Increase, Accrued Interest																									2,530
Debt Instrument, Unamortized Premium												$ 75,310													46,441
Debt Instrument, Convertible, Threshold Trading Days												180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger												58.00%
Interest and Debt Expense																							6,276		46,441
Debt Instrument, Periodic Payment, Interest		$ 2,872
Additionally Debt Instrument Unamortized Premium																							22,593
Repayments of Debt		137,915
Debt Instrument, Annual Principal Payment		$ 104,000
Convertible Note Payable Seven [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount													$ 58,000
Debt Instrument, Interest Rate, Stated Percentage													12.00%
Debt Instrument, Maturity Date													Jul. 27, 2015
Debt Instrument, Unamortized Premium													$ 58,000												36,411
Debt Instrument, Convertible, Threshold Trading Days													180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger													50.00%
Debt Instrument, Periodic Payment, Interest																									2,212
Repayments of Debt																									83,512
Debt Instrument, Annual Principal Payment																									58,000
Prepayment Penalties																									23,300
Debt Instrument, Increase (Decrease), Other, Net																									21,589
Convertible Note Payable Nine [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount										$ 17,500
Debt Instrument, Interest Rate, Stated Percentage										8.00%
Debt Instrument, Maturity Date										Apr. 20, 2016
Debt Instrument, Increase, Accrued Interest																							59		272
Debt Instrument, Unamortized Premium										$ 14,318
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger										55.00%
Debt Instrument, Periodic Payment, Principal																							16,500
Debt Instrument, Periodic Payment, Interest																							803
Additionally Debt Instrument Unamortized Premium																							13,500
Convertible Notes Payable Ten [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest									$ 671
Debt Instrument, Unamortized Discount									7,500
Debt Instrument, Unamortized Premium									$ 36,818
Debt Instrument, Convertible, Threshold Trading Days									180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger									55.00%
Interest and Debt Expense									$ 13,909														22,909		13,909
Debt Instrument, Periodic Payment, Principal																							45,000
Debt Instrument, Periodic Payment, Interest																							1,765
Additionally Debt Instrument Unamortized Premium																							36,818
Convertible Notes Payable Eleven [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest																							2,430		671
Debt Instrument, Unamortized Discount									7,500
Debt Instrument, Unamortized Premium									$ 36,818
Debt Instrument, Convertible, Threshold Trading Days									180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger									55.00%
Interest and Debt Expense																							22,909		13,909
Debt Instrument, Periodic Payment, Principal																							1,000
Debt Instrument, Periodic Payment, Interest																							46
Additionally Debt Instrument Unamortized Premium																							818
Convertible Notes Payable Twelve [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest																									$ 2,429
Debt Instrument, Unamortized Discount								$ 13,000
Debt Instrument, Unamortized Premium								$ 139,500
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger								55.00%
Debt Instrument, Periodic Payment, Principal																							170,500
Debt Instrument, Periodic Payment, Interest																							8,303
Additionally Debt Instrument Unamortized Premium																							$ 139,500

CONVERTIBLE NOTES (Details Te40

CONVERTIBLE NOTES (Details Textual 1)	Oct. 15, 2015USD ($)	Jul. 15, 2015USD ($)	Jul. 14, 2015USD ($)	Jun. 04, 2015USD ($)$ / shares	Jul. 02, 2014USD ($)$ / shares	Oct. 31, 2015USD ($)	Oct. 28, 2015USD ($)$ / sharesshares	Jun. 02, 2015USD ($)	May. 19, 2015USD ($)	Apr. 27, 2015USD ($)	Apr. 24, 2015USD ($)	Apr. 20, 2015USD ($)	Mar. 20, 2015USD ($)	Mar. 12, 2015USD ($)$ / shares	Feb. 20, 2015USD ($)	Feb. 17, 2015USD ($)	Feb. 15, 2015USD ($)	Feb. 10, 2015USD ($)	Jan. 27, 2015USD ($)	Jan. 26, 2015USD ($)	Jul. 18, 2014USD ($)	Dec. 31, 2015USD ($)$ / shares	Dec. 31, 2014USD ($)	Jun. 30, 2015USD ($)$ / shares	Jun. 30, 2014USD ($)$ / shares	Dec. 09, 2015USD ($)	Jul. 10, 2015$ / shares	Nov. 12, 2014$ / shares	Aug. 06, 2014USD ($)	Sep. 30, 2013$ / shares
Debt Instrument [Line Items]
Debt Instrument, Face Amount																													$ 250,000
Debt Instrument, Unamortized Discount				$ 20,000																									$ 25,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger									55.00%
Proceeds from Notes Payable																			$ 50,000
Noninterest Expense Transfer Agent and Custodian Fees																			7,779
Legal Fees																			2,500
Expense Related to Distribution or Servicing and Underwriting Fees																			5,000
Net Proceeds From Notes Issued				201,997															34,721
Amortization of debt discount																						$ 1,224,235	$ 117,231	$ 295,795	$ 49,029
Debt Conversion, Original Debt, Amount																					$ 50,000
Debt Conversion, Converted Instrument, Amount					$ 139,680																			$ 152,285	$ 0
Interest Payable																						7,339
Debt Instrument, Convertible, Conversion Price | $ / shares					$ 0.0709
Convertible Notes Payable			$ 352,500						$ 782,500													782,500
Debt Convertible Note cash Purchase				220,000
Proceeds from Interest Received				1,997
Proceeds from Sale of Notes Receivable	$ 407,735		17,690
Percentage Of Conversion Rate Of Lowest Trading Bid Price	55.00%
Accreted Put Premium	$ 351,818																					$ 179,818
Proceeds from Collection of Notes Receivable	430,000
Payments for Legal Settlements	$ 22,265
Common stock, par value | $ / shares																						$ 0.001		$ 0.001	$ 0.001		$ 0.001	$ 0.001
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares							$ 0.60																							$ 0.0698
Debt Discounts For Fees Paid																						$ 2,887,500	63,500
Six Month Consulting Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage																	5.00%
Debt Instrument, Maturity Date																	Aug. 15, 2015
Debt Instrument, Unamortized Premium																	$ 60,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																	60.00%
Debt Instrument, Increase, Accrued Interest																	$ 1,677					2,764
Additionally Debt Instrument Unamortized Premium																						56,667
Debt Conversion, Converted Instrument, Amount																	$ 90,000
Debt Instrument, Periodic Payment, Principal																						85,000
Two Year Consulting Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage														10.00%
Debt Instrument, Maturity Date														Mar. 11, 2017
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger														75.00%
Debt Conversion, Converted Instrument, Amount														$ 60,000
Interest Payable																						4,849		$ 1,825
Debt Instrument, Convertible, Conversion Price | $ / shares														$ 0.0175
Convertible Note Payable [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount				1,215,000
Debt Instrument, Unamortized Discount				$ 110,000																				529,500	$ 30,000
Debt Instrument, Increase, Accrued Interest																								$ 2,513
Debt Instrument, Percentage of Repayment, If prepaid within 60 days of the issuance date																								130.00%
Debt Instrument, Percentage of Repayment, if prepaid 60 but less than 121 days after the issuance date																								140.00%
Debt Instrument, Percentage of Repayment, if prepaid 120 but less than 180 days after the issuance date																								150.00%
Debt Instrument, Debt Default, Interest Rate																								24.00%
Proceeds from Notes Payable						$ 1,150,000
Additionally Debt Instrument Unamortized Premium																										$ 269,976
Amortization of debt discount																								$ 114,033	$ 3,133
Percentage of Consideration Received				10.00%
Promissory Note Payable Issued For Services						$ 50,000
Debt Instrument, Description						The Company issued the Promissory Note with a principal amount of $1,200,000 to the Lender. The Promissory Note has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Promissory Note; or (ii) June 24, 2016. On its face, the Promissory Note does not accrue any interest. In the event that the Lender does not proceed with a subsequent financing, beginning on the 46th day following the Issuance Date, the Note will have a one-time interest adjustment of $180,000 on the outstanding principal of the Promissory Note. Additionally, if the Lender does not wish to proceed with a subsequent financing, the Promissory Note will also be convertible into common stock at the lower of (i) $0.0346; or (ii) a twenty percent (20%) discount to the average of the two lowest closing prices of the common stock in the five trading days prior to the date of conversion.
Convertible Note Payable One [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																				$ 28,000
Debt Instrument, Interest Rate, Stated Percentage																				8.00%
Debt Instrument, Maturity Date																				Oct. 28, 2015
Debt Instrument, Unamortized Premium																				$ 20,276
Debt Instrument, Convertible, Threshold Trading Days																				180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																				58.00%
Debt Instrument, Increase, Accrued Interest																						29,468		835
Debt Instrument, Periodic Payment, Principal																								15,432
Repayments of Debt																								37,137
Debt Instrument, Annual Principal Payment																								28,000
Prepayment Penalties																								8,302
Debt Instrument, Increase (Decrease), Other, Net																								4,844
Convertible Note Payable Two [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Premium																			$ 40,909					40,909
Debt Instrument, Convertible, Threshold Trading Days																			180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																			55.00%
Additionally Debt Instrument Unamortized Premium																								40,909
Debt Conversion, Original Debt, Amount																								50,000
Interest Payable																								609
Convertible Note Payable Three [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																		$ 45,000
Debt Instrument, Interest Rate, Stated Percentage																		8.00%
Debt Instrument, Maturity Date																		Feb. 10, 2016
Debt Instrument, Unamortized Discount																		$ 7,500
Debt Instrument, Unamortized Premium																		$ 36,818						27,409
Debt Instrument, Convertible, Threshold Trading Days																		180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																		55.00%
Debt Instrument, Increase, Accrued Interest																								1,391
Convertible Note Payable Four [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																$ 45,000
Debt Instrument, Interest Rate, Stated Percentage																8.00%
Debt Instrument, Maturity Date																Feb. 17, 2016
Debt Instrument, Unamortized Discount																$ 7,500
Debt Instrument, Unamortized Premium																$ 36,818								27,409
Debt Instrument, Convertible, Threshold Trading Days																180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																55.00%
Debt Instrument, Increase, Accrued Interest																								1,322
Convertible Note Payable Five [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount														$ 170,500
Debt Instrument, Interest Rate, Stated Percentage														8.00%
Debt Instrument, Maturity Date														Mar. 12, 2016
Debt Instrument, Unamortized Discount														$ 13,000
Debt Instrument, Unamortized Premium														$ 139,500
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger														55.00%
Debt Instrument, Increase, Accrued Interest																								4,148
Convertible Note Payable Six [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount													$ 150,000
Debt Instrument, Interest Rate, Stated Percentage													8.00%
Debt Instrument, Maturity Date													Mar. 20, 2016
Debt Instrument, Unamortized Premium													$ 122,727
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger													55.00%
Debt Instrument, Increase, Accrued Interest																								3,386
Convertible Back-End Note Payable One [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																								45,000
Convertible Back-End Note Payable Two [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																								45,000
Convertible Back-End Note Payable Three [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																								170,500
Convertible Back-End Note Payable Four [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount																								150,000
Convertible Note Payable Seven [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount															$ 58,000
Debt Instrument, Interest Rate, Stated Percentage															12.00%
Debt Instrument, Maturity Date															Jul. 27, 2015
Debt Instrument, Unamortized Premium															$ 58,000									36,411
Debt Instrument, Convertible, Threshold Trading Days															180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger															50.00%
Repayments of Debt																								83,512
Debt Instrument, Annual Principal Payment																								58,000
Prepayment Penalties																								23,300
Debt Instrument, Increase (Decrease), Other, Net																								21,589
Debt Instrument, Periodic Payment, Interest																								2,212
Convertible Note Payable Eight [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount														$ 104,000
Debt Instrument, Interest Rate, Stated Percentage														8.00%
Debt Instrument, Maturity Date														Dec. 16, 2015
Debt Instrument, Unamortized Premium														$ 75,310										46,441
Debt Instrument, Convertible, Threshold Trading Days														180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger														58.00%
Debt Instrument, Increase, Accrued Interest																								2,530
Interest and Debt Expense																						6,276		46,441
Additionally Debt Instrument Unamortized Premium																						22,593
Repayments of Debt		$ 137,915
Debt Instrument, Annual Principal Payment		104,000
Debt Instrument, Periodic Payment, Interest		$ 2,872
Convertible Notes Payable Ten [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount											$ 7,500
Debt Instrument, Unamortized Premium											$ 36,818
Debt Instrument, Convertible, Threshold Trading Days											180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger											55.00%
Debt Instrument, Increase, Accrued Interest											$ 671
Interest and Debt Expense											13,909											22,909		13,909
Proceeds from Notes Payable											45,000
Legal Fees											2,250
Net Proceeds From Notes Issued											35,250
Additionally Debt Instrument Unamortized Premium																						36,818
Debt Instrument, Periodic Payment, Principal																						45,000
Debt Instrument, Periodic Payment, Interest																						1,765
Convertible Notes Payable Eleven [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount											7,500
Debt Instrument, Unamortized Premium											$ 36,818
Debt Instrument, Convertible, Threshold Trading Days											180
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger											55.00%
Debt Instrument, Increase, Accrued Interest																						2,430		671
Interest and Debt Expense																						22,909		13,909
Proceeds from Notes Payable											$ 45,000
Legal Fees											2,250
Net Proceeds From Notes Issued											$ 35,250
Additionally Debt Instrument Unamortized Premium																						818
Debt Instrument, Periodic Payment, Principal																						1,000
Debt Instrument, Periodic Payment, Interest																						46
Convertible Notes Payable Twelve [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount										$ 13,000
Debt Instrument, Unamortized Premium										$ 139,500
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger										55.00%
Debt Instrument, Increase, Accrued Interest																								2,429
Proceeds from Notes Payable										$ 170,500
Legal Fees										7,500
Net Proceeds From Notes Issued										$ 150,000
Additionally Debt Instrument Unamortized Premium																						139,500
Debt Instrument, Periodic Payment, Principal																						170,500
Debt Instrument, Periodic Payment, Interest																						8,303
Convertible Promissory Back-End Notes One [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									37,500
Convertible Promissory Back-End Notes Two [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									37,500
Convertible Promissory Back-End Notes Three [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									157,500
Convertible Promissory Back-End Notes Four [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									150,000
Convertible Promissory Back-End Notes Five [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									17,500
Convertible Promissory Back-End Notes Six [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									37,500
Convertible Promissory Back-End Notes Seven [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									37,500
Convertible Promissory Back-End Notes Eight [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									157,500
Convertible Promissory Back-End Notes Nine [Member]
Debt Instrument [Line Items]
Convertible Notes Payable									$ 150,000
Convertible Notes Payable Fourteen [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Premium								$ 122,727														288,409
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger								55.00%
Debt Instrument, Increase, Accrued Interest																						12,308		2,137
Proceeds from Notes Payable								$ 150,000
Legal Fees								7,500
Net Proceeds From Notes Issued			334,810					$ 142,500
Additionally Debt Instrument Unamortized Premium			$ 288,409																			16,364
Debt Instrument, Periodic Payment, Principal																						20,000
Debt Instrument, Periodic Payment, Interest																						690
Secured Investor Note One [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount				$ 30,000
Legal Fees				5,000
Debt Convertible Note cash Purchase				335,000
Secured Investor Note Two [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount				20,000
Debt Convertible Note cash Purchase				220,000
Secured Investor Note Three [Member]
Debt Instrument [Line Items]
Debt Instrument, Unamortized Discount				20,000
Debt Convertible Note cash Purchase				$ 220,000
Execution Note [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				10.00%
Debt Instrument, Unamortized Discount				$ 30,000
Legal Fees				$ 5,000
Debt Instrument, Convertible, Conversion Price | $ / shares				$ 0.07
Debt Convertible Note cash Purchase				$ 300,000
Secured Debt, Secured Percentage by Lender				40.00%
Market Capitalization Minimum Amount				$ 3,000,000
Convertible Note Payable Nine [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount												$ 17,500
Debt Instrument, Interest Rate, Stated Percentage												8.00%
Debt Instrument, Maturity Date												Apr. 20, 2016
Debt Instrument, Unamortized Premium												$ 14,318
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger												55.00%
Debt Instrument, Increase, Accrued Interest																						59		$ 272
Additionally Debt Instrument Unamortized Premium																						13,500
Debt Instrument, Periodic Payment, Principal																						16,500
Debt Instrument, Periodic Payment, Interest																						803
Convertible Notes Payable Thirteen [Member]
Debt Instrument [Line Items]
Debt Instrument, Increase, Accrued Interest																						5,740
Additionally Debt Instrument Unamortized Premium																						36,818
Debt Instrument, Periodic Payment, Principal																						45,000
Debt Instrument, Periodic Payment, Interest																						2,140
Securities Purchase Agreement [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount							$ 4,400,000
Debt Instrument, Increase (Decrease), Other, Net							25,000
Cancellation Of Debt							1,200,000
Debt Issuance Cost							$ 50,000
Warrant Issued To Purchase Of Shares | shares							26,190,476
Warrants Term							4 years
Common stock, par value | $ / shares							$ 0.001
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares							$ 0.60
Amount Will Be Deposited Into Deposit Control Account							$ 2,800,000
Debt Instrument Increase Decrease Reason For Registration Effective							$ 25,000
Debenture [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage							5.00%
Debt Instrument, Debt Default, Interest Rate							18.00%
Debt Instrument, Description							payable quarterly in cash (or if certain conditions are met, in stock at the Company’s option) on January 1, April 1, July 1 and October 1. The Debenture is convertible at any time, in whole or in part, at the Purchaser’s option into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price equal to $0.042, which is the volume weighted average price of the Company’s Common Stock five days prior to the execution of the Debenture (subject to adjustment) (the “Conversion Price”). At any time after the effective date of the registration statement, the Purchaser has the opportunity to convert up to an aggregate of $2,090,000 of the Debenture, at one or more conversion dates, into shares of Common Stock at a conversion price equal to the VWAP of the Common Stock over the five (5) trading days prior to such Effective Date. The Purchaser option to convert at such a conversion price expires when the Purchaser converts an aggregate of $2,090,000 of the Debenture using such conversion price. If the volume weighted average price of the Company Common Stock on any trading day is less than the Conversion Price, the Purchaser may convert at a price per share equal to a twenty percent (20%) discount to the average of the two lowest closing prices during the five trading days prior to the date of conversion. At no time will the Purchaser be entitled to convert any portion of the Debenture to the extent that after such conversion, the Purchaser (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date. During the six months ended December 31, 2015, the Company withdrew a principal amount of $1,225,000 from the deposit control account, of which $269,976 was paid directly as partial payment of a note dated June 4, 2015 and $33,437 were paid directly to legal fees resulting in net cash proceeds of $921,587 received by the Company. An aggregate total of $2,090,000 of these notes were bifurcated with the embedded conversion option recorded as a derivative liability at fair value (See Note 10). The remaining principal of $335,000 did not have a beneficial conversion feature value since its conversion price was higher than the fair value of the Company’s common stock. Accrued interest as of December 31, 2015 was $17,844.
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares							$ 0.60
Discount On Debt Issued Percentage							10.00%
Debt Discounts [Member]
Debt Instrument [Line Items]
Amortization of debt discount																						$ 961,735	$ 23,970

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - Warrant [Member] - USD ($)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Number of Shares Outstanding-Beginning Balance (In shares)	3,000,000	0
Number of Shares-Issued	4,379,158	3,000,000
Number of Shares-Exercised	0	0
Number of Shares-Expired	0	0
Number of Shares Outstanding-Ending Balance (In shares)	7,379,158	3,000,000
Number of Shares Exercisable	7,379,158
Outstanding and Exercisable:
Number of Shares-Weighted average remaining contractual term	4 years 2 months 16 days
Number of Shares-Aggregate intrinsic value	$ 319,774
Weighted Average Price pre share-Beginning Balance	$ 0.07	$ 0
Weighted Average Price pre share-Issued	0.04	0.07
Weighted Average Price pre share-Exercised	0	0
Weighted Average Price pre share-Expired	0	0
Weighted Average Price pre share-Ending Balance	0.05	$ 0.07
Weighted Average Price Per Shares Exercisable	$ 0.05

STOCKHOLDERS' DEFICIT (Details

STOCKHOLDERS' DEFICIT (Details Textual) - USD ($)	Jan. 04, 2016	Dec. 28, 2015	Dec. 23, 2015	Dec. 21, 2015	Dec. 17, 2015	Dec. 16, 2015	Dec. 15, 2015	Dec. 11, 2015	Dec. 10, 2015	Dec. 08, 2015	Dec. 04, 2015	Nov. 30, 2015	Nov. 24, 2015	Nov. 23, 2015	Oct. 16, 2015	Oct. 15, 2015	Oct. 13, 2015	Oct. 08, 2015	Oct. 07, 2015	Sep. 16, 2015	Sep. 08, 2015	Sep. 04, 2015	Aug. 14, 2015	Jul. 02, 2015	Jun. 16, 2015	Jun. 05, 2015	Jun. 04, 2015	Jun. 03, 2015	May. 07, 2015	Apr. 14, 2015	Mar. 17, 2015	Mar. 16, 2015	Mar. 12, 2015	Mar. 11, 2015	Mar. 06, 2015	Feb. 17, 2015	Feb. 09, 2015	Feb. 04, 2015	Feb. 02, 2015	Dec. 10, 2014	Dec. 09, 2014	Dec. 04, 2014	Nov. 04, 2014	Aug. 07, 2014	Jul. 02, 2014	May. 09, 2014	Apr. 30, 2016	Dec. 30, 2015	Dec. 29, 2015	Nov. 17, 2015	Oct. 31, 2015	Oct. 31, 2015	Oct. 28, 2015	Sep. 22, 2015	Sep. 18, 2015	Sep. 01, 2015	Aug. 26, 2015	Jul. 24, 2015	May. 21, 2015	Apr. 28, 2015	Apr. 21, 2015	Apr. 15, 2015	Mar. 20, 2015	Mar. 19, 2015	Mar. 18, 2015	Jan. 30, 2015	Dec. 26, 2014	Dec. 24, 2014	Dec. 16, 2014	Dec. 11, 2014	Nov. 05, 2014	Oct. 17, 2014	Sep. 11, 2014	Jul. 18, 2014	Nov. 30, 2013	Oct. 31, 2013	Sep. 30, 2013	Jul. 31, 2013	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013	Jul. 10, 2015	Feb. 28, 2015	Nov. 12, 2014	Oct. 31, 2014
Debt Instrument, Convertible, Conversion Price																																													$ 0.0709
Debt Conversion, Converted Instrument, Amount																																													$ 139,680																																					$ 152,285	$ 0
Debt Instrument, Periodic Payment																																													$ 154,798
Stock Issued During Period, Shares, New Issues																																																				1,500,000
Warrants Expire Period																																																					4 years																								5 years
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants																																																					$ 26,190,476																								$ 3,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights																																																					$ 0.60																								$ 0.0698
Debt Conversion, Converted Instrument, Shares Issued																																													2,183,333
Stock Issued During Period, Shares, Issued for Services																																										3,000,000
Stock Issued During Period, Value, Issued for Services																																																																																		$ 741,276	$ 244,500
Common stock, authorized shares																																																																																2,000,000,000		2,000,000,000	2,000,000,000		10,000,000,000		100,000,000
Common stock, par value																																																																																$ 0.001		$ 0.001	$ 0.001		$ 0.001		$ 0.001
Debt Conversion, Original Debt, Amount																																																																										$ 50,000
Class of Warrant or Right, Outstanding																																																																																33,569,634		7,379,158
Share Price																																																																																$ 0.0279		$ 0.0899
Scientific Advisory Board [Member]
Stock Issued During Period, Shares, Issued for Services																					600,000
Shares Issued, Price Per Share																					$ 0.0369
Stock Issued During Period, Value, Issued for Services																					$ 22,140
Common Stock [Member]
Debt Instrument, Convertible, Conversion Price																																																																		$ 0.0025																$ 0.0025
Debt Conversion, Converted Instrument, Amount																																																																		$ 25,000																$ 25,000
Debt Conversion, Converted Instrument, Shares Issued																																																																		10,000,000																10,000,000
Stock Issued During Period, Shares, Issued for Services																																																																																		19,258,316	1,915,000
Shares Issued, Price Per Share																																						$ 0.0025
Stock Issued During Period, Value, Issued for Services																																																																																		$ 19,258	$ 1,915
Common stock, authorized shares																																																																																					2,000,000,000		10,000,000,000
Common stock, par value																																																																																$ 0.001		$ 0.001			$ 0.001		$ 0.001
Stock Issued During Period, Shares, Conversion of Convertible Securities																																																																																		181,185,110
Common Stock [Member] | Investment Banking Service Agreement [Member]
Stock Issued During Period, Shares, Issued for Services																																																																												500,000
Shares Issued, Price Per Share																																																																												$ 0.10
Stock Issued During Period, Value, Issued for Services																																																																												$ 50,000
Preferred Stock [Member]
Preferred stock, authorized shares																																																																																10,000,000		10,000,000
Preferred stock, par value																																																																																$ 0.01		$ 0.01
Director [Member]
Debt Conversion, Converted Instrument, Amount																																						$ 14,000
Debt Conversion, Converted Instrument, Shares Issued																																						17,654,470
Investor [Member]
Stock Issued During Period, Shares, Issued for Services																																																																					9,400,000	1,000,000	3,000,000
Shares Issued, Price Per Share																																																																					$ 0.0025	$ 0.0025	$ 0.001
Stock Issued During Period, Value, Issued for Services																																																																					$ 23,500	$ 2,500	$ 3,000
First Tranche [Member]
Stock Issued During Period, Shares, New Issues																																																																									7,426,000
Second Tranche [Member]
Stock Issued During Period, Shares, New Issues																																											8,161,000
Debt Settlement Agreements [Member] | Director [Member]
Debt Conversion, Converted Instrument, Amount																																						$ 44,136
Debt Conversion, Converted Instrument, Shares Issued																																						17,654,470
Consultant [Member]
Stock Issued During Period, Shares, Issued for Services																		8,000,000			600,000			500,000			500,000															4,000,000		500,000		1,000,000	1,500,000					1,500,000					560,000			500,000		6,000,000										10,000,000								560,000		100,000
Shares Issued, Price Per Share															$ 0.0415												$ 0.0706																			$ 0.10					$ 0.031	$ 0.031					$ 0.04															$ 0.008
Stock Issued During Period, Value, Issued for Services																											$ 35,300																			$ 100,000						$ 46,500																				$ 80,000								$ 30,285
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																																																			400,000	400,000																											3,000,000		3,000,000					3,000,000		4,000,000
Stock Issued During Period, Value, New Issues																																																			$ 11,720
Accrued Professional Fees, Current															$ 166,000																																																																	68,940
Consultant [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services	1,000,000														4,000,000									500,000		6,758,316	500,000	1,000,000	6,758,316																			1,000,000											1,000,000																			300,000
Shares Issued, Price Per Share																											$ 0.0706		$ 0.043																			$ 0.0260											$ 0.0445																			$ 0.20
Stock Issued During Period, Value, Issued for Services																										$ 88,446	$ 35,300	$ 7,265	$ 290,608																														$ 44,500																			$ 12,000		15,461		$ 5,015		$ 48,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																													3,379,158																														1,000,000
Share Price																													$ 0.043																														$ 0.0445
Accrued Professional Fees, Current																																																$ 26,000																																189
Consultant [Member] | Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price																													$ 0.03																														$ 0.07
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate																													397.00%																														397.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term																													60 months																														60 months
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate																													1.54%																														1.54%
Warrants and Rights Outstanding																													$ 145,303																														$ 44,500
Prepaid Expense																													101,080																														37,235
Share-based Compensation, Total																													$ 44,223																														$ 7,265
Consultant One [Member]
Stock Issued During Period, Shares, New Issues															4,000,000																																	1,000,000				1,100,000
Stock Issued During Period, Shares, Issued for Services																																																										8,000,000																								80,000
Shares Issued, Price Per Share																																																										$ 0.0435
Stock Issued During Period, Value, Issued for Services																																																										$ 348,000																						407,581
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized																																																										8,000,000
Consultant One [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																														250,000
Shares Issued, Price Per Share																																																																														$ 0.20
Stock Issued During Period, Value, Issued for Services																																																																														$ 50,000
Consultant Two [Member]
Stock Issued During Period, Value, New Issues																																																																																$ 299,246
Consultant Two [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																														137,500
Shares Issued, Price Per Share																																																																														$ 0.20
Stock Issued During Period, Value, Issued for Services																																																																														$ 27,500
Consultant Three [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																														10,000
Shares Issued, Price Per Share																																																																														$ 0.20
Stock Issued During Period, Value, Issued for Services																																																																														$ 2,000
Consultant Four [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																														150,000
Shares Issued, Price Per Share																																																																														$ 0.20
Stock Issued During Period, Value, Issued for Services																																																																														$ 30,000
Consultant Six [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																													300,000
Shares Issued, Price Per Share																																																																													$ 0.20
Stock Issued During Period, Value, Issued for Services																																																																													$ 60,000
Consultant Seven [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																													25,000
Shares Issued, Price Per Share																																																																													$ 0.20
Stock Issued During Period, Value, Issued for Services																																																																													$ 5,000
Consultant Eight [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																												200,000
Shares Issued, Price Per Share																																																																												$ 0.10
Stock Issued During Period, Value, Issued for Services																																																																												$ 13,333
Increase (Decrease) in Prepaid Expense																																																																												$ 6,667
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																																																																												3 years
Consultant Nine [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																												100,000
Shares Issued, Price Per Share																																																																												$ 0.10
Stock Issued During Period, Value, Issued for Services																																																																												$ 10,000
Consultant Ten [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																											30,000
Shares Issued, Price Per Share																																																																											$ 0.10
Stock Issued During Period, Value, Issued for Services																																																																											$ 3,000
Consultant Eleven [Member] | Common Stock [Member]
Stock Issued During Period, Shares, Issued for Services																																																																											25,000
Shares Issued, Price Per Share																																																																											$ 0.10
Stock Issued During Period, Value, Issued for Services																																																																											$ 2,500
Issue One [Member]
Debt Instrument, Convertible, Conversion Price																							$ 0.02365							$ 0.0020	$ 0.0017	$ 0.0017	$ 0.0015	$ 0.0015	$ 0.0006	$ 0.0006	$ 0.0035		$ 0.0006	$ 0.0011	$ 0.0011																				$ 0.0020	$ 0.0020	$ 0.0020	$ 0.0020	$ 0.0020		$ 0.0007	$ 0.0007	$ 0.0012
Debt Instrument, Periodic Payment																														$ 4,271	$ 1,061	$ 15,534	$ 1,001	$ 14,675	$ 3,410	$ 3,266	$ 21,100		$ 3,446																						$ 28,202	$ 10,145	$ 23,762	$ 8,260	$ 20,053		$ 4,044	$ 3,762	$ 6,000
Debt Conversion, Converted Instrument, Shares Issued																							866,796																	6,698,331	4,870,391
Debt Conversion, Original Debt, Amount																							$ 20,500																	$ 7,368	$ 5,357
Stock Issued During Period, Shares, Conversion of Convertible Securities																														2,135,450	622,504	9,110,833	674,141	9,882,013	6,200,000	5,937,563	6,089,544		6,265,964																						14,100,870	5,072,740	12,001,242	4,171,808	10,127,576		5,655,958	5,700,000	5,194,805
Issue Two [Member]
Debt Instrument, Convertible, Conversion Price																							$ 0.02365								$ 0.0019		$ 0.0015	$ 0.0015	$ 0.0015	$ 0.0035
Debt Instrument, Periodic Payment																															$ 20,048		$ 14,678	$ 10,121	$ 6,443	$ 15,323
Debt Conversion, Converted Instrument, Shares Issued																							879,585
Debt Conversion, Original Debt, Amount																							$ 20,802
Stock Issued During Period, Shares, Conversion of Convertible Securities																															10,414,660		9,884,155	6,815,185	4,338,384	4,422,257
Issue Three [Member]
Debt Instrument, Convertible, Conversion Price																																	$ 0.0016		$ 0.0015																						$ 0.018425
Debt Instrument, Periodic Payment																																	$ 10,125		$ 1,011
Debt Conversion, Converted Instrument, Shares Issued																																																									1,414,843
Debt Conversion, Original Debt, Amount																																																									$ 26,068
Stock Issued During Period, Shares, Conversion of Convertible Securities																																	6,347,918		680,485
Issue Four [Member]
Debt Instrument, Convertible, Conversion Price																																																								$ 0.018425
Debt Conversion, Converted Instrument, Shares Issued																																																								1,396,108
Debt Conversion, Original Debt, Amount																																																								$ 25,723
Issue Five [Member]
Debt Instrument, Convertible, Conversion Price																						$ 0.018425
Debt Conversion, Converted Instrument, Shares Issued																						849,263
Debt Conversion, Original Debt, Amount																						$ 15,648
Issue Six [Member]
Debt Instrument, Convertible, Conversion Price																				$ 0.018975
Debt Conversion, Converted Instrument, Shares Issued																				826,726
Debt Conversion, Original Debt, Amount																				$ 15,687
Issue Six [Member] | Consultant [Member]
Stock Issued During Period, Shares, Issued for Services																											500,000
Issue Seven [Member]
Debt Instrument, Convertible, Conversion Price																																																							$ 0.017875
Debt Conversion, Converted Instrument, Shares Issued																																																							877,969
Debt Conversion, Original Debt, Amount																																																							$ 15,694
Issue Eight [Member]
Debt Instrument, Convertible, Conversion Price																																																						$ 0.01716
Debt Conversion, Converted Instrument, Shares Issued																																																						911,294
Debt Conversion, Original Debt, Amount																																																						$ 15,638
Issue Nine [Member]
Debt Instrument, Convertible, Conversion Price																																																			$ 0.012375	$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																																																				2,152,289
Debt Conversion, Original Debt, Amount																																																				$ 26,635
Issue Ten [Member]
Debt Instrument, Convertible, Conversion Price																			$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																			2,535,293
Debt Conversion, Original Debt, Amount																			$ 31,374
Issue Eleven [Member]
Debt Instrument, Convertible, Conversion Price																	$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																	8,808,435
Debt Conversion, Original Debt, Amount																	$ 109,004
Issue Twelve [Member]
Debt Instrument, Convertible, Conversion Price																	$ 0.012375
Debt Conversion, Converted Instrument, Shares Issued																	8,461,602
Debt Conversion, Original Debt, Amount																	$ 104,712
Issue Thirteen [Member]
Debt Instrument, Convertible, Conversion Price																$ 0.01
Debt Conversion, Converted Instrument, Shares Issued																5,000,000
Debt Conversion, Original Debt, Amount																$ 50,000
Issue Fourteen [Member]
Debt Instrument, Convertible, Conversion Price																																																		$ 0.01986
Debt Conversion, Converted Instrument, Shares Issued																																																		105,709
Debt Conversion, Original Debt, Amount																																																		$ 2,099
Issue Fifteen [Member]
Debt Instrument, Convertible, Conversion Price																																																		$ 0.01
Debt Conversion, Converted Instrument, Shares Issued																																																		3,500,000
Debt Conversion, Original Debt, Amount																																																		$ 35,000
Issue Sixteen [Member]
Debt Instrument, Convertible, Conversion Price			$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued														1,019,925
Debt Conversion, Original Debt, Amount														$ 15,707
Issue Seventeen [Member]
Debt Instrument, Convertible, Conversion Price													$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued													1,360,185
Debt Conversion, Original Debt, Amount													$ 20,947
Issue Eighteen [Member]
Debt Instrument, Convertible, Conversion Price												$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued												3,200,448
Debt Conversion, Original Debt, Amount												$ 49,287
Issue Nineteen [Member]
Debt Instrument, Convertible, Conversion Price											$ 0.0154
Debt Conversion, Converted Instrument, Shares Issued											2,058,637
Debt Conversion, Original Debt, Amount											$ 31,703
Issue Twenty [Member]
Debt Instrument, Convertible, Conversion Price										$ 0.01595
Debt Conversion, Converted Instrument, Shares Issued										3,963,207
Debt Conversion, Original Debt, Amount										$ 63,213
Issue Twenty One [Member]
Debt Instrument, Convertible, Conversion Price								$ 0.02608
Debt Conversion, Converted Instrument, Shares Issued								1,917,178
Debt Conversion, Original Debt, Amount								$ 50,000
Issue Twenty Two [Member]
Debt Instrument, Convertible, Conversion Price							$ 0.02712
Debt Conversion, Converted Instrument, Shares Issued							1,843,658
Debt Conversion, Original Debt, Amount							$ 50,000
Issue Twenty Three [Member]
Debt Instrument, Convertible, Conversion Price						$ 0.01650
Debt Conversion, Converted Instrument, Shares Issued						1,926,177
Debt Conversion, Original Debt, Amount						$ 31,782
Issue Twenty Four [Member]
Debt Instrument, Convertible, Conversion Price					$ 0.02500
Debt Conversion, Converted Instrument, Shares Issued					1,600,000
Debt Conversion, Original Debt, Amount					$ 40,000
Issue Twenty Five [Member]
Debt Instrument, Convertible, Conversion Price				$ 0.02360
Debt Conversion, Converted Instrument, Shares Issued				1,694,916
Debt Conversion, Original Debt, Amount				$ 40,000
Issue Twenty Six [Member]
Debt Instrument, Convertible, Conversion Price				$ 0.01584
Debt Conversion, Converted Instrument, Shares Issued				3,265,069
Debt Conversion, Original Debt, Amount				$ 51,719
Issue Twenty Seven [Member]
Debt Instrument, Convertible, Conversion Price			$ 0.02320
Debt Conversion, Converted Instrument, Shares Issued			1,724,138
Debt Conversion, Original Debt, Amount			$ 40,000
Issue Twenty Eight [Member]
Debt Instrument, Convertible, Conversion Price			$ 0.01584
Debt Conversion, Converted Instrument, Shares Issued			1,983,188
Debt Conversion, Original Debt, Amount			$ 31,414
Issue Twenty Nine [Member]
Debt Instrument, Convertible, Conversion Price		$ 0.02320
Debt Conversion, Converted Instrument, Shares Issued		1,724,138
Debt Conversion, Original Debt, Amount		$ 40,000
Issue Thirty [Member]
Debt Instrument, Convertible, Conversion Price																																																	$ 0.01573
Debt Conversion, Converted Instrument, Shares Issued																																																	999,783
Debt Conversion, Original Debt, Amount																																																	$ 15,727
Issue Thirty One [Member]
Debt Instrument, Convertible, Conversion Price																																																$ 0.02284
Debt Conversion, Converted Instrument, Shares Issued									1,751,314
Debt Conversion, Original Debt, Amount									$ 40,000
Loans from Directors [Member]
Debt Conversion, Converted Instrument, Amount																																						$ 27,000
Debt Conversion, Converted Instrument, Shares Issued																																						33,259,350
Loans from Directors [Member] | Director [Member]
Debt Instrument, Convertible, Conversion Price																																						$ 0.0025
Debt Conversion, Converted Instrument, Amount																																						$ 41,000
Loans from Directors [Member] | Debt Settlement Agreements [Member]
Debt Conversion, Converted Instrument, Amount																																						$ 83,148
Debt Conversion, Converted Instrument, Shares Issued																																						33,259,350
Series A Preferred Stock [Member]
Stock Issued During Period, Shares, New Issues																																																																															8,161,000		8,161,000
Preferred stock, authorized shares																																									500,000																																							10,000,000		10,000,000	10,000,000
Preferred stock, par value																																									$ 0.01																																							$ 0.01		$ 0.01	$ 0.01
Stock Issued During Period, Shares, Issued for Services																																									500,000																																									500,000	0
Shares Issued, Price Per Share																																																																															$ 0.00213	$ 0.00213	$ 0.00213
Stock Issued During Period, Value, Issued for Services																																																																															$ 1,067			$ 5,000	$ 0
Stock Issued During Period, Value, New Issues																																																																																	$ 1,067
Stock Issued During Period, Shares, Conversion of Convertible Securities																																																																																		0
Series B Preferred Stock [Member]
Preferred stock, authorized shares																																																																																5		5	5
Preferred stock, par value																									$ 0.01																																																							$ 0.01		$ 0.01	$ 0.01
Stock Issued During Period, Shares, Issued for Services																																																																																		1	0
Shares Issued, Price Per Share																									$ 0.1165																																																									$ 0.1165
Stock Issued During Period, Value, Issued for Services																									$ 0.12																																																									$ 0	$ 0
Stock Issued During Period, Shares, Conversion of Convertible Securities																																																																																		0

COMMITMENTS AND CONTINGIENCIES

COMMITMENTS AND CONTINGIENCIES (Details Textual) - USD ($)	Jul. 02, 2014	Oct. 31, 2015	May. 31, 2015	Jan. 30, 2015	Jul. 31, 2014	Jul. 18, 2014	May. 31, 2014	Nov. 30, 2009	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Apr. 30, 2015	Jul. 31, 2013
Commitments And Contingencies [Line Items]
Operating Leases, Rent Expense											$ 9,827	$ 5,344	$ 3,719	$ 11,016
Accrued Rent																$ 1,000
Sale of Stock, Number of Shares Issued in Transaction													15,587,000
Sale Of Stock Decreased liability Owed To Purchaser													$ 52,907
Debt Instrument, Convertible, Conversion Price	$ 0.0709
Payments for Fees						$ 50,000
Debt Conversion, Original Debt, Amount						$ 50,000
Interest Expense, Debt													405,000
Stock Issued During Period, Shares, New Issues		1,500,000
Long-term Purchase Commitment, Period						24 months
Other Liabilities				$ 575,000
Debt Conversion, Converted Instrument, Shares Issued	2,183,333
Debt Conversion, Converted Instrument, Amount	$ 139,680												152,285	0
Interest Payable									$ 7,339		7,339
Conversion of Stock, Amount Converted											636,348	37,032	71,370	0
Gains (Losses) on Extinguishment of Debt, Total									$ (58,893)	$ 71,147	(58,893)	$ 34,884	$ 375,547	$ 0
Common Stock [Member]
Commitments And Contingencies [Line Items]
Debt Instrument, Convertible, Conversion Price				$ 0.0025									$ 0.0025
Debt Conversion, Converted Instrument, Shares Issued				10,000,000									10,000,000
Debt Conversion, Converted Instrument, Amount				$ 25,000									$ 25,000
Promissory Note [Member]
Commitments And Contingencies [Line Items]
Debt Instrument, Convertible, Conversion Price													$ 0.0025
Debt Conversion, Original Debt, Amount							$ 25,000
Debt Conversion, Converted Instrument, Amount				50,000
Interest Payable				1,466
Conversion of Stock, Amount Converted				25,000									$ 25,000
Gains (Losses) on Extinguishment of Debt, Total				51,466
Repayments of Notes Payable											$ 90,000
Settlement Agreement [Member] | Promissory Note [Member]
Commitments And Contingencies [Line Items]
Interest Payable							1,466
Equity Purchase Agreement [Member] | Investor [Member]
Commitments And Contingencies [Line Items]
Percentage Of Common Stock Outstanding						9.99%
Percentage Of Market Price Of Common Stock						90.00%
Long-term Purchase Commitment, Amount						$ 5,000,000
Purchaser [Member]
Commitments And Contingencies [Line Items]
Debt Instrument, Unamortized Premium				310,000
Debt Instrument, Fee Amount				$ 67,000
Purchaser [Member] | Share-based Compensation Award, Tranche One [Member]
Commitments And Contingencies [Line Items]
Stock Issued During Period, Shares, New Issues													15,587,000
Purchaser [Member] | Settlement Agreement [Member]
Commitments And Contingencies [Line Items]
Payments for Fees							$ 25,000
Percentage Of Net Proceeds From Issuance Of Common Stock					65.00%
Percentage Of Common Stock Outstanding					9.99%
Loss Contingency, Damages Sought, Value					$ 627,998
Obligated to Issue Common Stock to Purchaser					$ 50,000
Percentage of Average Closing Bid Prices					75.00%
Purchaser [Member] | Equity Purchase Agreement [Member]
Commitments And Contingencies [Line Items]
Obligated to Issue Common Stock to Purchaser													$ 1,033,000
Lease Agreements [Member]
Commitments And Contingencies [Line Items]
Payments for Fees			$ 2,200
Royalty Agreement Terms [Member]
Commitments And Contingencies [Line Items]
Operating Leases Income Statement Revenue Percentage								2.00%
License Agreement Terms [Member]
Commitments And Contingencies [Line Items]
Accrued Rent															$ 21,000
Operating Leases Income Statement Revenue Percentage								5.00%

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)	Feb. 04, 2015	Jul. 02, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014
Related Party Transaction [Line Items]
Due to Related Parties, Current			$ 33,471		$ 33,471		$ 35,108	$ 60,350
Loans From Related Party			54,005		54,005		79,416	161,975
Debt Conversion, Converted Instrument, Shares Issued		2,183,333
Debt Conversion, Converted Instrument, Amount		$ 139,680					152,285	0
Debt Instrument, Convertible, Conversion Price		$ 0.0709
Conversion of Stock, Amount Converted					636,348	$ 37,032	71,370	0
Gains (Losses) on Extinguishment of Debt, Total			(58,893)	$ 71,147	(58,893)	$ 34,884	375,547	0
Loans from Directors [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	33,259,350
Debt Conversion, Converted Instrument, Amount	$ 27,000
Director [Member]
Related Party Transaction [Line Items]
Loans From Related Party			54,005		54,005		79,416	161,975
Debt Conversion, Converted Instrument, Shares Issued	17,654,470
Debt Conversion, Converted Instrument, Amount	$ 14,000
Director [Member] | Loans from Directors [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Amount	$ 41,000
Debt Instrument, Convertible, Conversion Price	$ 0.0025
Conversion of Stock, Amount Converted	$ 127,284
Gains (Losses) on Extinguishment of Debt, Total	$ 86,455
Two Directors [Member]
Related Party Transaction [Line Items]
Due to Related Parties, Current			$ 33,471		$ 33,471		$ 35,108	$ 60,350

CONCENTRATIONS AND RISKS (Detai

CONCENTRATIONS AND RISKS (Details Textual)	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014
Reimbursement On Goods And Service Tax Receivable Percentage	100.00%	100.00%	100.00%

DERIVATIVE FINANCIAL INSTRUME46

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details)	3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 30, 2013	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014
Convertible Debt [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility		296.00%	408.00%
Expected remaining term		1 year
Risk-free interest rate		0.60%	0.64%
Convertible Debt [Member] | Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility				377.00%
Expected remaining term		1 year 2 months 8 days	1 year 8 months 12 days	2 years
Risk-free interest rate				0.70%
Convertible Debt [Member] | Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility				216.00%
Expected remaining term		3 months 4 days	9 months 25 days	9 months 29 days
Risk-free interest rate				0.50%
Warrants [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility	53.00%	296.00%	408.00%	134.00%
Expected remaining term	5 years	2 years 9 months	3 years 3 months	4 years 3 months
Risk-free interest rate	0.40%	1.31%	1.63%	0.47%
Expected dividend yield		0.00%
Initial Valuations On Derivative [Member] | Convertible Debt [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Volatility		296.00%
Risk-free interest rate		0.70%
Expected dividend yield		0.00%

DERIVATIVE FINANCIAL INSTRUME47

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details 1) - USD ($)	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Derivative [Line Items]
Embedded conversion option liabilities	$ 2,511,405	$ 780,281
Fair value of liability for warrant derivative instruments	82,086	269,648	$ 158,244
Total	2,593,491	1,049,929	158,244	$ 0
Fair Value, Inputs, Level 1 [Member]
Derivative [Line Items]
Embedded conversion option liabilities	0	0
Fair value of liability for warrant derivative instruments	0	0	0
Total	0	0
Fair Value, Inputs, Level 2 [Member]
Derivative [Line Items]
Embedded conversion option liabilities	0	0
Fair value of liability for warrant derivative instruments	0	0	0
Total	0	0
Fair Value, Inputs, Level 3 [Member]
Derivative [Line Items]
Embedded conversion option liabilities	2,511,405	780,281
Fair value of liability for warrant derivative instruments	82,086	269,648	$ 158,244
Total	$ 2,593,491	$ 1,049,929

DERIVATIVE FINANCIAL INSTRUME48

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details 2) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014
Balance at Beginning	$ 1,049,929	$ 158,244	$ 0
Effects of foreign currency exchange rate changes	(14,253)	(42,796)	(2,519)
Initial fair value of embedded conversion option derivative liability recorded as debt discount	1,005,925	392,500	144,241
Initial fair value of embedded conversion option derivative liability recorded as change in fair value of ECO	1,369,261	1,082,567
Change in fair value included in statements of operations	(817,371)	(540,586)	16,522
Balance at Ending	$ 2,593,491	$ 1,049,929	$ 158,244

DERIVATIVE FINANCIAL INSTRUME49

DERIVATIVE FINANCIAL INSTRUMENTS and FAIR VALUE MEASUREMENTS (Details Textual) - USD ($)	Dec. 31, 2015	Jun. 30, 2015
Derivative Instruments And Hedging Activities [Line Items]
Class of Warrant or Right, Outstanding	33,569,634	7,379,158
Share Price	$ 0.0279	$ 0.0899
Repricing option [Member]
Derivative Instruments And Hedging Activities [Line Items]
Convertible Debt	$ 2,375,024	$ 335,000
Variable conversion pricing [Member]
Derivative Instruments And Hedging Activities [Line Items]
Class of Warrant or Right, Outstanding	3,000,000	3,000,000
Convertible Debt	$ 60,000	$ 87,500

SUBSEQUENT EVENTS (Details Text

SUBSEQUENT EVENTS (Details Textual) - USD ($)	Feb. 04, 2016	Feb. 03, 2016	Feb. 01, 2016	Jan. 29, 2016	Jan. 27, 2016	Jan. 25, 2016	Jan. 21, 2016	Jan. 20, 2016	Jan. 19, 2016	Jan. 14, 2016	Jan. 13, 2016	Jan. 12, 2016	Jan. 11, 2016	Jan. 08, 2016	Jan. 06, 2016	Jan. 04, 2016	Sep. 16, 2015	Sep. 08, 2015	Sep. 04, 2015	Aug. 14, 2015	Jul. 15, 2015	Jul. 14, 2015	Jun. 03, 2015	Dec. 04, 2014	Jul. 02, 2014	Dec. 31, 2015	Dec. 30, 2015	Sep. 24, 2015	Sep. 22, 2015	Sep. 18, 2015	Sep. 01, 2015	Aug. 26, 2015	May. 19, 2015	Jan. 30, 2015	Jan. 27, 2015	Jul. 18, 2014	Dec. 31, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 04, 2015	Feb. 04, 2015	Aug. 06, 2014
Subsequent Event [Line Items]
Proceeds from Notes Payable																																			$ 50,000
Debt Conversion, Converted Instrument, Shares Issued																									2,183,333
Debt Conversion, Original Debt, Amount																																				$ 50,000
Debt Instrument, Convertible, Conversion Price																									$ 0.0709
Legal Fees																																			$ 2,500
Debt Instrument, Unamortized Discount																																								$ 20,000		$ 25,000
Stock Issued During Period, Shares, Issued for Services																								3,000,000
Debt Instrument, Face Amount																																										$ 250,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																																	55.00%
Debt Conversion, Converted Instrument, Amount																									$ 139,680													$ 152,285	$ 0
Stock Issued During Period, Value, Issued for Services																																						$ 741,276	$ 244,500
Common Stock [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued																																		10,000,000				10,000,000
Debt Instrument, Convertible, Conversion Price																																		$ 0.0025				$ 0.0025
Shares Issued, Price Per Share																																									$ 0.0025
Stock Issued During Period, Shares, Issued for Services																																						19,258,316	1,915,000
Debt Conversion, Converted Instrument, Amount																																		$ 25,000				$ 25,000
Stock Issued During Period, Value, Issued for Services																																						19,258	$ 1,915
Promissory Note [Member]
Subsequent Event [Line Items]
Debt Instrument, Unamortized Discount																										$ 2,341,232											$ 2,341,232	415,467	$ 121,059
Consultant [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share																											$ 0.0279
Stock Issued During Period, Shares, Issued for Services																											2,250,000										2,250,000
Stock Issued During Period, Value, Issued for Services																											$ 62,775
Law Firm [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share																										$ 0.0279											$ 0.0279
Stock Issued During Period, Shares, Issued for Services																										1,600,000											1,600,000
Stock Issued During Period, Value, Issued for Services																										$ 44,640
Subsequent Event [Member]
Subsequent Event [Line Items]
Repayments of Debt																					$ 137,915
Debt Instrument, Annual Principal Payment																					104,000
Debt Instrument, Periodic Payment, Interest																					2,872
Debt Instrument Prepayment Penalty																					$ 31,043
Subsequent Event [Member] | Secured Investor Note [Member]
Subsequent Event [Line Items]
Debt Instrument, Unamortized Discount																																						20,000
Secured Debt																																						$ 220,000
Proceeds from Issuance of Secured Debt																							$ 201,997
Interest Proceeds Received																							$ 1,997
Shares Issued, Price Per Share																																						$ 0.07
Subsequent Event [Member] | Three Notes Issued [Member]
Subsequent Event [Line Items]
Proceeds from Notes Payable																						$ 352,500
Legal Fees																						17,690
Net Proceeds From Notes Payable																						$ 334,810
Subsequent Event [Member] | Conversion Notice [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	1,760,564	1,351,352	1,679,800	1,657,825	1,573,161	1,675,604	1,680,108	513,158	1,047,013	4,901,786	946,889	827,632	764,573	1,992,032	1,934,236	1,468,187	826,726		849,263	866,796									911,294	877,969	1,396,108	1,414,843
Debt Conversion, Original Debt, Amount																	$ 15,687		$ 15,648	$ 20,500									$ 15,638	$ 15,694	$ 25,723	$ 26,068
Debt Instrument, Convertible, Conversion Price	$ 0.0142	$ 0.0148	$ 0.009955	$ 0.015080	$ 0.009955	$ 0.01492	$ 0.01488	$ 0.009955	$ 0.009955	$ 0.0168	$ 0.01864	$ 0.012705	$ 0.01375	$ 0.02008	$ 0.02068	$ 0.0143	$ 0.018975		$ 0.018425	$ 0.02365									$ 0.01716	$ 0.017875	$ 0.018425	$ 0.018425
Debt Conversion, Converted Instrument, Amount	$ 25,000	$ 20,000	$ 16,722	$ 25,000	$ 15,661	$ 25,000	$ 25,000	$ 5,108	$ 10,423	$ 82,350	$ 17,650	$ 10,515	$ 10,513	$ 40,000	$ 40,000	$ 20,995
Subsequent Event [Member] | Conversion Notice One [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued	2,779,927	1,111,737				1,362,834	1,256,944				889,409			761,050	1,485,946	2,522,032				879,585
Debt Conversion, Original Debt, Amount																				$ 20,802
Debt Instrument, Convertible, Conversion Price	$ 0.009405	$ 0.009405				$ 0.009955	$ 0.009955				$ 0.011825			$ 0.0113805	$ 0.014135	$ 0.02156				$ 0.02365
Debt Conversion, Converted Instrument, Amount	$ 26,145	$ 10,456				$ 13,567	$ 12,513				$ 10,517			$ 10,506	$ 21,004	$ 54,375
Subsequent Event [Member] | Conversion Notice Two [Member]
Subsequent Event [Line Items]
Debt Conversion, Converted Instrument, Shares Issued											1,971,565
Debt Instrument, Convertible, Conversion Price											$ 0.01056
Debt Conversion, Converted Instrument, Amount											$ 20,820
Subsequent Event [Member] | Promissory Note [Member]
Subsequent Event [Line Items]
Debt Conversion, Original Debt, Amount																												$ 1,200,000
Debt Instrument, Convertible, Conversion Price																												$ 0.0346
Debt Instrument, Issuance Date																												Sep. 24, 2015
Debt Instrument, Face Amount																												$ 1,200,000
Debt Instrument, Increase, Accrued Interest																												$ 180,000
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger																												20.00%
Debt Instrument, Maturity Date, Description																												The debenture has a maturity date of the earlier of: (i) the date on which the Company closes a subsequent equity offering in an amount greater than the principal amount of the Note; or (ii) June 24, 2016.
Subsequent Event [Member] | Consultant [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share																																$ 0.04
Stock Issued During Period, Shares, Issued for Services																375,000																560,000
Subsequent Event [Member] | Scientific Advisory Board [Member]
Subsequent Event [Line Items]
Shares Issued, Price Per Share																		$ 0.0369
Stock Issued During Period, Shares, Issued for Services																		600,000
Subsequent Event [Member] | Law Firm [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Issued for Services																1,600,000
Subsequent Event [Member] | Law Firm [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Stock Issued During Period, Shares, Issued for Services																1,000,000